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Objectives 
In the pathogenesis of periodontitis, Porphyromonas gingivalis plays a role as a 
keystone pathogen that dysregulates host immune responses and results in 
dysbiosis in oral microbial communities. Arg-gingipains (RgpA and RgpB) and 
Lys-gingipain (Kgp) are essential to the virulence of P. gingivalis. Therefore, 
gingipains are often considered as therapeutic targets. The aim of this study was to 
elucidate the roles of gingipains in caspase-1 activation in P. gingivalis-infected 
macrophages and to investigate the roles of gingipains in the modulation by P. 
gingivalis of phagocytosis of Tannerella forsythia by macrophages. 
 
Methods 
Macrophages differentiated from THP-1 cells with phorbol-12-myristate-13-acetate 
(PMA) and peripheral blood mononuclear cells (PBMC)-derived macrophages 
 
 
were infected with P. gingivalis or its gingipain mutants for 6 hours to determine 
whether P. gingivalis activates caspase-1 and whether gingipain mutation affects 
the caspase-1 activation. Caspase-1, interleukin (IL)-1β, and lactate dehydrogenase 
(LDH) in the culture supernatants were analyzed with immunoblot, ELISA, and 
LDH cytotoxicity assay. To examine the role of gingipain protease activity, 
macrophages were infected with P. gingivalis in the presence or absence of 
leupeptin, a cysteine protease inhibitor, or P. gingivalis preincubated with 
gingipain-specific inhibitors, KYT-1 and KYT-36. Degradation of proteins that 
were released from cells upon caspase-1 activation was analyzed after incubation 
of P. gingivalis in the culture supernatants of macrophages that had been stimulated 
with heat-killed P. gingivalis. Intracellular caspase-1 activity and ATP release were 
measured after infection with P. gingivalis and its gingipain mutants, or P. 
gingivalis preincubated with KYT-1 or KYT-36. To assess the effect of processing 
of surface proteins by gingipains on caspase-1 activation, cells were infected with 
the gingipain-null mutant that had been cultured overnight with gingipain-
containing culture supernatants of P. gingivalis. 
To determine whether P. gingivalis coinfection has an effect on T. forsythia 
phagocytosis, PMA-differentiated THP-1 cells and PBMC-derived macrophages 
were infected with carboxyfluorescein diacetate succinimidyl ester (CFSE)-
labelled T. forsythia in the presence or absence of P. gingivalis or its gingipain 
mutants for 1 hour. Phagocytosis of T. forsythia was analyzed by flow cytometry 
and confocal microscopy. Coaggregation between the two bacterial species was 
assessed, and the effect of amino acids that inhibit the coaggregation on T. forsythia 
phagocytosis was examined. The role of gingipain protease activity was determined 
using KYT-1 and KYT-36. Intracellular persistence/survival of T. forsythia was 
 
 
analyzed by flow cytometry, confocal microscopy, and 16S rRNA-based viability 
assay after antibiotic protection. 
 
Results 
Infection with P. gingivalis at low multiplicity of infections (MOIs), but not at high 
MOIs, resulted in low levels of IL-1β and LDH without detectable active caspase-1 
in the culture supernatants. The proteins released from caspase-1-activated cells 
were rapidly degraded by gingipains. However, P. gingivalis expressing gingipains 
induced higher intracellular caspase-1 activity in the infected cells than the 
gingipain-null mutant. The increased intracellular caspase-1 activity was associated 
with ATP release from the infected cells. In addition, growing the gingipain-null 
mutant in the culture supernatants containing gingipains enhanced caspase-1 
activation by the mutant. In contrast, inhibition of the protease activity of Kgp or 
Rgp increased the caspase-1-activating potential of wild-type P. gingivalis, 
indicating an inhibitory effect of the protease activities of Kgp and Rgp.  
Phagocytosis of T. forsythia was significantly enhanced by coinfection with P. 
gingivalis in an MOI- and gingipain-dependent manner. Mutation of either Kgp or 
Rgp in the coinfecting P. gingivalis resulted in attenuated enhancement of T. 
forsythia phagocytosis. Inhibition of coaggregation between the two bacterial 
species reduced phagocytosis of T. forsythia in the mixed infection, and the 
coaggregation was dependent on gingipains. Inhibition of gingipain protease 
activities in coinfecting P. gingivalis abated the coaggregation and the enhancement 
of T. forsythia phagocytosis. However, direct effect of protease activities of 
gingipains on T. forsythia seemed to be minimal. Although most of the 
phagocytosed T. forsythia were cleared in infected cells, more T. forsythia 
 
 
remained in cells coinfected with gingipain-expressing P. gingivalis than in cells 
coinfected with the gingipain-null mutant or infected only with T. forsythia at 24 
and 48 hours post-infection.  
 
Conclusion 
Considering that gingipains are major promising therapeutic targets, it is of great 
importance to fully characterize the roles of gingipains in the pathogenicity of P. 
gingivalis. This study demonstrated that gingipains play contradictory roles in 
caspase-1 activation by P. gingivalis monoinfection, and that gingipains are 
essential in the augmentation of T. forsythia phagocytosis in the mixed infection. 
This study provides clues to the role of gingipains in the mechanism by which P. 
gingivalis dysregulates host immune responses. 
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1. Periodontitis  
1.1. Periodontitis: definition, prevalence, and outcomes 
Periodontitis is a chronic inflammatory disease caused by complex 
interactions between bacteria in subgingival biofilms and host immune responses. 
Its consequence is the destruction of the tooth-supporting tissues, which are 
comprised of the periodontal ligament, gingival, cementum, and alveolar bone. 
Periodontitis is one of major causes of tooth loss in adults. Periodontitis, along with 
dental caries, is the most important oral health burden worldwide. It is one of the 
most common chronic inflammatory diseases in adult populations, with severe 
periodontitis found in 5-15% of the global adult population [1]. Children and 
adolescents can also be affected by several forms of periodontitis including 
aggressive periodontitis, chronic periodontitis, and periodontitis as a manifestation 
of systemic diseases [2]. For example, early-onset aggressive periodontitis has been 
reported to affect 2% of young individuals and causes premature tooth loss [1]. 
Despite improvement in oral hygiene practices and advances in our understanding 
of periodontitis pathogenesis over the last few decades, the prevalence of severe 
periodontitis has not decreased [3,4]. 
Numerous epidemiological studies have shown the association of periodontal 
diseases with multiple systemic conditions [5]. On one hand, along with behavioral 
factors, such as smoking, alcohol consumption, some systemic conditions such as 
diabetes mellitus, obesity, and metabolic syndrome are risk factors for periodontal 
diseases [6]. On the other hand, periodontitis is associated with an increased risk 
for several systemic diseases including cardiovascular diseases, diabetes, 
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rheumatoid arthritis, and adverse pregnancy outcomes [7]. To explain the 
association, several hypotheses have been suggested: the common susceptibility 
model (genetic susceptibility), systemic inflammation model (increased level of 
circulating cytokines and inflammatory mediators), direct infection model (direct 
infection of distant tissues like blood vessels by bacterial dissemination), and cross-
reactivity/molecular mimicry model (cross-reactivity of T cells and antibodies 
specific for bacterial antigens with self-antigens) [8].  
 
1.2. Pathogenesis of periodontitis  
The most important etiologic factor in the pathogenesis of periodontitis is 
polymicrobial biofilms in the subgingival crevice although complex interactions of 
other etiological factors, including systemic health status, genetic factors, and 
behavioral factors, are involved [6]. The classical study by Socransky et al. [9] 
categorized numerous bacterial species in subgingival plaque samples into 5 major 
microbial complexes (red, orange, yellow, green, and purple) of bacteria based on 
their association with periodontitis. The so-called “red-complex” consortium 
comprising Porphyromonas gingivalis, Tannerella forsythia, and Treponema 
denticola have been considered as the disease-causing agents of periodontitis. 
Recent studies using 16S rRNA gene sequencing have suggested that some novel 
microorganisms such as Filifactor alocis and Synergistetes species are also 
associated with periodontitis [10-12].  
A recent model for periodontitis pathogenesis suggests that polymicrobial 
synergy and dysbiosis (PSD), but not individual pathogens, causes periodontal 
diseases [13,14]. In this model, transition from periodontal health to disease is 
caused by a shift from symbiosis to dysbiosis in the subgingival microbiota. 
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Dysbiotic microbiota overactivate the inflammatory responses, resulting in tissue 
destruction, which further facilitates dysbiosis by providing nutrients and 
environmental niches to pathogens [15]. The initial shift to dysbiosis is driven by 
colonization of keystone pathogens and their immune subversion [16]. Keystone 
pathogens, even at low-abundance, can increase the quantity of the normal 
microbiota and change the microbial composition in the oral cavity. These changes 
in turn support and stabilize dysbiosis and cause inflammation. A representative 
keystone pathogen is P. gingivalis [14]. 
 
2. Porphyromonas gingivalis 
2.1. General characteristics of P. gingivalis 
P. gingivalis is a Gram-negative, asaccharolytic, obligatory anaerobe. Its 
characteristic black-pigmented colonies on blood agar plates are caused by 
accumulation of hemin (iron protoporphyrin IX, derived from erythrocytic 
hemoglobin) on the bacterial surface and within bacterial cells [17]. P. gingivalis is 
detected frequently in subgingival biofilms of periodontitis patients (up to 85% 
compared to 23% in those of healthy individuals) [18]. Its number is positively 
correlated with pocket depth, a representative clinical indicator of periodontitis 
[19]. P. gingivalis has been implicated in the development and progression of 
systemic diseases [20]. For example, its association with cardiovascular disease has 
been supported by its detection in human atherosclerotic plaques [21] and in vivo 
animal studies [22]. P. gingivalis has also been implicated in rheumatoid arthritis 




2.2. Virulence factors of P. gingivalis 
P. gingivalis exhibits both immune stimulatory and evasive properties [24], 
which contribute to the pathogenesis of periodontitis and its associated systemic 
diseases [16]. Virulence of P. gingivalis varies depending on the strains [25-27], 
and its high pathogenic potential has mainly been ascribed to its ability to evade the 
host immune system. Key virulence factors (Table 1) of P. gingivalis include 
lipopolysaccharide (LPS), fimbriae, serine phosphatase (SerB), nucleotide 
diphosphate kinase (NDK), and multiple proteases [28,29]. P. gingivalis expresses 
modified forms of LPS, which suppress Toll-like receptor (TLR)-4 signaling [30] 
and non-canonical inflammasome activation [22]. Its major fimbriae (FimA) inhibit 
the TLR2-dependent antimicrobial pathway through the interaction with CXC-
chemokine receptor 4 (CXCR4) [31]. P. gingivalis utilizes its minor fimbriae (Mfa1) 
to bind DC-SIGN for entry to and survival within dendritic cells (DC), and 
subversion of DC functions [32]. SerB dephosphorylates Ser536 residue of p65 
subunit of NF-κB, resulting in inhibition of its nuclear translocation and 
interleukin-8 (IL-8) production in gingivalis epithelial cells [33]. P. gingivalis 
hydrolyzes ATP using its NDK, which inhibits ATP-induced apoptosis of epithelial 










Table 1. Virulence factors of P. gingivalis involved in immune subversion 
Virulence factor Mechanism References 
Lipid A 1- and 4’-
phosphatases,  
lipid A deacylase 
Lipid A modifications [22,30,36] 
SerB Dephosphorylation of NF-kB p65 [33] 
Peptidylarginine deiminase Citrullination of host proteins [23] 




Binding to host cells and tissue 
: Invasion  
Dysregulation of host defense responses  
[31,32,37] 
Gingipains 
(RgpA, RgpB, Kgp) 
Binding to host cells  
Degradation of host defense proteins (cytokines, 
chemokines, antibacterial peptides) 
Complement inactivation 
Cleavage of cell surface receptors 
[38-48] 














2.3. Gingipains  
2.3.1. Characteristics of gingipains 
Because P. gingivalis is asaccharolytic and dependent on peptides and proteins as 
nutrient sources, it produces various endopeptidases and exopeptidases [29]. 
Among its multiple proteolytic enzymes, cysteine proteases referred to as 
gingipains [Arg-X-specific Arg gingipains (RgpA and RgpB) and Lys-X-specific 
Lys gingipain (Kgp)] are responsible for most of the proteolytic activity (at least 
85%) of P. gingivalis [49]. RgpA and Kgp are multi-domain proteins and contain 
hemagglutinin/adhesin domains as well as catalytic domains (Fig. 1A) [50,51]. 
Gingipains can be produced as outer membrane-associated forms or secreted forms 
via the Por secretion system (Fig. 1A) [52-54]. Gingipains perform diverse 
functions both in bacteria and during the infection process. They are indispensible 
not only for nutrient uptake and growth [55] but also for the maturation of other P. 
gingivalis virulence factors such as major and minor fimbriae, periodontain and 











Figure 1. Schematic representation of structures, secretion of gingipains and 
their role in processing of bacterial proteins [29,51,52,54]. IM, inner membrane; 
OM, outer membrane; SP, signal peptide; Pro, prodomain; HA, hemagglutinin/ 
adhesion domain; CT, C-terminal domain; HArep, hemagglutinin/adhesin repeats 
in gingipains, HagA, and TonB-associated adhesin domain; HbR, hemoglobin-
binding receptor; OMP, outer membrane protein.  
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2.3.2. Functions of gingipains in the pathogenesis of periodontitis 
Gingipains are essential to the pathogenic potential of P. gingivalis [50,55,57]. 
They are involved in most stages during the establishment of P. gingivalis infection, 
including adhesion, invasion, and survival [58,59]. Gingipains contribute to the 
bacterial adhesion to host cells through processing other bacterial surface proteins 
like major and minor fimbriae, as well as the adhesin domains of RgpA and Kgp 
[38,56]. The pathogenicity of P. gingivalis is further facilitated by the disruptive 
and evasive proteolytic effects of gingipains on host innate immune responses, via 
dysregulation of cytokine/chemokine networks, complement systems, intracellular 
signaling, and cell proliferation/death [39-41]. Gingipains degrades complement 
factors such as C3 [43] as well as proinflammatory cytokines like IL-6 and IL-8 
[44], while C5a generated by Arg-gingipains can bind C5aR and inhibits nitric 
oxide production in macrophages [45]. Gingipains also have several subversive 
effects on the adaptive immune system. The proteases inactivate some effector 
cytokines like IL-4 as well as immunoglobulins [42,46,47] and attenuate T-cell 
proliferation by inhibiting IL-2 accumulation [48]. Thus, gingipains are regarded as 
promising therapeutic targets for the prevention and treatment of periodontitis and 
associated systemic diseases. 
 
3. Tannerella forsythia 
3.1. General characteristics of T. forsythia 
T. forsythia, another member of the “red complex” consortium, is a Gram-
negative, rod-shaped, asaccharolytic, obligatory anaerobe. It is also implicated in 
an increased risk for systemic inflammation like cardiovascular disease [21,60,61]. 
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Although T. forsythia is relatively less characterized than P. gingivalis because of 
its fastidious growth requirements, recent studies have identified several virulence 
factors that T. forsythia utilizes to modulate host immune responses. 
 
3.2. Virulence factors of T. forsythia 
Representative virulence factors include BspA, surface-layer (S-layer)-
associated glycoproteins, lipoproteins, glycosidases, and proteases [29,62]. A cell 
surface-associated and secreted protein BspA, which binds to TLR-2, mediates 
binding and entry of T. forsythia into oral epithelial cells and leads to IL-8 
production [63,64]. It also binds to fibronectin and fibrinogen in the extracellular 
matrix [65]. In vivo studies have shown that BspA is responsible for T. forsythia-
induced alveolar bone loss and can facilitate atherosclerosis in mice [60,64,66]. 
The cell surface S-layer contributes to serum resistance of T. forsythia [67] as well 
as adhesion and invasion into oral epithelial cells [68]. It delays inflammatory 
responses in macrophages [69], and glycosylation of S-layer suppresses the 
expression of cytokines related to T helper 17 responses in macrophages and DCs 
[70]. Karilysin, a metalloprotease, has been demonstrated to inhibit all the three 
complement pathways and to increase soluble TNF-α concentration by cleaving the 
membrane-bound form of TNF-α [71,72]. T. forsythia expresses surface 
lipoproteins that can induce expression of proinflammatory cytokines. It also 
expresses several glycosidases that may jeopardize the functional integrity of the 





4. Mixed infection with P. gingivalis and T. forsythia 
4.1. Interspecies bacterial interaction 
Previous studies that used traditional culture methods and those that used 
recent culture-independent methods have identified more than 700 species of 
bacteria in human oral cavity [73]. With substantial diversity among people, 
approximately 100-200 species are found in the oral cavity of an individual [73]. 
Among microbial habitats in the oral cavity, such as gingival sulcus, teeth, tongue, 
and cheeks as well as carious lesions and endodontic infections, over 400 species 
of bacteria have been detected in subgingival biofilm [74,75]. Polymicrobial 
communities are developed through interspecies interactions and adaptation within 
the surrounding microenvironments. Interspecies bacterial interactions in a 
polymicrobial community involve communication via direct contact as well as 
soluble mediators [76]. Outcomes of interbacterial interactions are different from 
the simple sum of activites observed with each bacterial species [77]. The 
interactions include neutralism (no effect on each other), competition (for growth-
limiting nutrients and physical resources), commensalism (one benefits from the 
other, but not vice versa), mutualism (synergy in growth or survival), and 
ammensalism (indirect negative effect, such as production of an antagonist that 
inhibits the growth of the other). Furthermore, interference or promotion of 
growth-dependent signaling, or neutralization of virulence factors of one species by 
another species is also possible [78].  
 
4.2. Synergistic pathogenicity of P. gingivalis and T. forsythia 
P. gingivalis is frequently isolated together with T. forsythia as complexes 
within the microbial communities of active periodontitis lesions [9,10]. In addition, 
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mixed infection of T. forsythia and P. gingivalis has been shown to cause 
synergistic abscess formation and additive alveolar bone loss in murine models 
[79,80]. This synergism between the two bacterial species can be attributed to 
several factors. T. forsythia stimulates the growth of P. gingivalis [81], and P. 
gingivalis promotes the growth of T. forsythia in multi-species biofilms [82], 
indicating their symbiotic relationship. Karilysin of T. forsythia and Arg-gingipains 
of P. gingivalis synergistically inactivate complement pathways [72]. In addition, P. 
gingivalis enhances invasion of T. forsythia into oral epithelial cells [63]. Although 
some studies have failed to find synergistic inflammatory responses to mixed 
infection with P. gingivalis and T. forsythia [83,84], this combination of bacteria 
synergistically induces IL-6 production in murine macrophages [85].  
 
5. Macrophages and phagocytosis 
5.1. Role of macrophages in periodontitis 
Macrophages were first identified as phagocytic cells by Metchnikoff. Along 
with monocytes and DCs, they belong to the mononuclear phagocytic system, 
which is derived from committed hematopoietic stem cells in bone marrow [86]. 
Macrophages are found in all body tissues with great diversity in their phenotypes 
and functions. They respond to environmental challenges as well as to 
physiological changes through their diverse receptors including cytokine receptors, 
pattern recognition receptors, and phagocytic receptors [87]. Macrophages play 
pivotal roles in host defense, inflammation, and tissue homeostasis. They function 
as sentinel cells by moving throughout tissues and sensing non-self or damaged 
tissues, which initiates phagocytosis and clearance by macrophages [88]. 
Classically activated macrophages (M1) mediate inflammatory responses through 
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production of pro-inflammatory mediators, such as reactive oxygen and nitrogen 
species, proinflammatory cytokines, and chemokines. However, depending on the 
activation conditions, they can switch to anti-inflammatory phenotypes (M2, 
alternatively activated macrophages) and participate in tissue repair/remodeling 
and maintenance of homeostasis. Macrophages are also important players in the 
development of adaptive immunity by activating or suppressing T cells through 
their role as antigen presenting cells [89].  
In a healthy periodontium, it is essential to maintain a controlled immune-
inflammatory state in response to normal symbiotic microbiota. In periodontitis, 
overt inflammation leads to periodontal tissue destruction. Macrophages play 
complicated roles in the pathogenesis of periodontitis. First of all, macrophages, 
together with neutrophils, are responsible for phagocytosis of invading microbes 
and foreign substances, which is essential to limit propagation of infection and 
inflammation. Because the oral cavity and gingival tissues can be an entry to the 
inside of the body, clearance of invading pathogens in gingival tissues is important 
to prevent persistent infection and systemic dissemination of an invading pathogen. 
They are also involved in resolution of inflammation and maintenance of tissue 
homeostasis in gingival tissues [90].  
Macrophages, on the other hand, can inadvertently contribute to the 
progression of periodontitis through inflammation and tissue destruction. 
Infiltration of macrophages in gingival tissues increases in active periodontitis 
lesions compared to inactive sites or healthy tissues [91,92], and their infiltration 
increases with the progression of periodontitis [93]. Macrophages are major 
immune cells that produce inflammatory cytokines such as IL-1 and TNF-α as well 
as chemokines including MIP-1α and IL-8, which lead to further recruitment and 
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activation of inflammatory cells [90]. It has been reported that depletion of 
macrophages reduces alveolar bone loss in a mouse periodontitis model [92], 
indicating that excessive macrophage infiltration can be detrimental to periodontal 
health. Macrophages are precursor cells that can be differentiated into osteoclasts 
in the presence of macrophage colony-stimulating factor (M-CSF) and receptor 
activator of nuclear factor κB ligand (RANKL). In addition, proinflammatory 
cytokines such as IL-1 and IL-6 from macrophages can promote osteoclastogenesis 
[94]. Macrophages contribute to tissue destruction by degrading extracellular 
matrix and providing attachment sites for osteoclasts by degrading the 
demineralized organic bone matrix [95].  
 
5.2. Phagocytosis in macrophages 
Phagocytosis is one of three major strategies to internalize extracellular 
substances. Large particles (> 0.5 μm) such as bacteria are engulfed by cells via 
phagocytosis whereas pinocytosis is a process for internalizing solutes and fluid. 
Receptor-mediated endocytosis is mainly involved in uptake of macromolecules, 
small particles, and virus [96]. The mechanism of phagocytosis is remarkably 
complex. A diverse array of receptors and signaling pathways are involved, and the 
mechanism shows substantial heterogeneity depending on the features of particles 
and receptors [97].  
The initial step of phagocytosis is particle recognition. Direct recognition of 
microbes is mediated by receptors that identify ligands on the microbial surfaces, 
such as mannose receptor (CD206), dectins, scavenger receptors (SR-A, MARCO, 
and CD36), CD14, and integrins (CD11b/CD18) [96,98]. Alternatively, phagocytes 
recognize particles that are opsonized with mannose binding proteins, surfactant 
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protein A, immunoglobulins, or complement (C3b, C4b, and iC3b) via C1q 
receptor, SPR210, Fc receptors, or complement receptors, respectively [96,98]. 
Particles with multiple ligands, like bacteria, are recognized by several receptors 
that can synergize or antagonize each other. Furthermore, non-phagocytic receptors 
influence activity of phagocytic receptors. For example, activation of TLR-2, 3, 4, 
and 9 promotes phagocytosis in macrophages via upregulation of scavenger 
receptors, Fc receptors, and complement receptors [99,100]. In addition, binding of 
P. gingivalis fimbriae to TLR2 transactivates complement receptor CR3 via inside-
out signaling [101].  
Particle recognition initiates the process for particle internalization: actin 
rearrangement, membrane extension around the particles, and membrane fusion to 
form phagosomes. This process involves multiple signaling pathways including 
protein kinase C, phosphoinositide 3-kinase, phospholipase C, Rho family of 
GTPase, and motor proteins such as myosin [102]. Phagosomes then fuse with 
acidic lysosomes to form mature phagolysomes, where microbes are killed and 
particles are digested by reactive oxygen and nitrogen species, antimicrobial 
proteins, and hydrolytic enzymes [103].  
Phagocytosis is a major defense strategy against microorganisms that breach 
the epithelial barrier and is connected to inflammatory responses. Recognition of 
the specific nature of pathogens is facilitated after phagolysomal fusion via pattern 
recognition receptors located in the lysosomal compartment. This enables 
macrophages to exhibit immune responses tailored to specific pathogens [97]. For 
instance, differential signal transduction pathways are activated by engagement of 
different combination of TLRs, resulting in different inflammatory responses. After 
phagocytic killing of microbes, MHC class II molecules are loaded with peptides 
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derived from microbes. The MHC/peptide complexes are then presented to cognate 
T cells in the presence of cytokines that macrophages have produced. This antigen 
presentation process guides adaptive immunity [89]. Engulfment of apoptotic 
bodies, called efferocytosis, contributes to resolution of inflammation through 
induction of anti-inflammatory cytokines, such as TGF-β and IL-10 [104-106]. 
Efferocytosis also facilitates clearance of some microbes such as Mycobacterium 
tuberculosis and Streptococcus pneumonia [107,108]. However, some pathogens 
have developed strategies to survive within macrophages through escaping 
phagosomes (Listeria monocytogenes and Shigella flexneri), inhibiting phagosomal 
maturation (Mycobacterium spp. and Salmonella spp.), survival in phagolysosome 
(Legionella pneumophila, Leishmania spp. (amastigotes), and Coxiella burnetii), or 
inhibiting cell death (Toxoplasma gondii) [109]. In these circumstances, 
macrophages provide intracellular niches, where the pathogens are protected from 
antibodies or antimicrobial effectors, and can promote dissemination of the 
pathogens [110].  
 
6. Inflammasome  
6.1. Inflammasome and caspase-1 activation 
Caspase-1, along with caspase-4 and caspase-5, belongs to the inflammatory 
caspase subfamily, which plays a central role in the regulation of inflammation and 
host defenses against microbial infection [111]. Like other caspases, caspase-1 is 
produced as a zymogen, pro-caspase-1, consisting of a caspase recruitment domain 
(CARD domain), a large subunit (p20), and a small subunit (p10) (Fig. 2) [112]. 
Caspase-1 becomes proteolytically active by forming two heterodimers of p20 and 




Inflammasome assembly results from the activation of intracellular innate 
immune sensors that include several members of the NOD-like receptor (NLR) 
family (NLRP1, NLRP3, NLRP6, NLRP7, NLRP12, NAIP1/2/5/6, and NLRC4) 
and PYHIN family (AIM2, IFI16, and PYRIN), by specific pathogen-associated 
molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) 
(Fig. 2A and B, Table 2) [114,115]. In most cases, the adaptor ASC (apoptosis-
associated speck-like protein with a caspase-recruitment domain) is needed, and 
ASC proteins assemble to form large protein aggregates or specks [116]. 
Noncanonical activation of caspase-1 involves caspase-11 or human caspase-4 
binding/activation by cytosolic LPS, which leads to assembly of NLRP3 
inflammasome and activation of caspase-1 (Fig. 2C) [117,118]. In addition, 
caspase-8-dependent activation of caspase-1 by Yersinia pestis and its virulence 
factor YopJalso has been reported, and the activation is independent of 














Figure 2. Canonical and non-canonical activation of caspase-1 [115,118]. BIR, 
baculovirus inhibitor of apoptosis domain; CARD, caspase recruitment domain; 
DD, death domain; DED, death effector domain; HIN200, hematopoietic 
interferon-inducible nuclear proteins with a 200 amino acid repeat; LRR, leucine 
rich repeat; NACHT, NAIP, CIITA, HETE and TP1 domain; PK, protein kinase; 




Table 2. Inflammasome activation by bacterial infection [115,121,122] 
Inflammasome Signaling mechanism Ligands/stimulants 
NLRP1 Proteolytic cleavage Anthrax lethal toxin 
NLRP3 




Pore forming toxins:  
V. cholera (Hyl), EHEC, S. aureus (hemolysin), 
L. monocytogenes (LLO),  
S. pneumoniae (pneumolysin) 
Extracellular ATP (via P2X7 receptor) 
Complement 
T. denticola (Td92), F. nucleatum, P. gingivalis 
Caspase-4/11 
Cytosolic LPS: 
Burkholderia, Haemophilus, Proteus, Vibrio 
NLRP6  Commensal microbiota 
NLRP7  
Acyl lipopeptide: L. monocytogenes,  
        S. aureus, Mycoplasma 




T3SS needle proteins: 
Chromobacterium violaceum (Cprl), 
Salmonella Typhimurium (Prgl), 
EHEC (E. prl), B. thailandensis (BsaL),  
S. flexneri (Mxil), P. aeruginosa (PscF) 
NAIP2  
T3SS rod proteins: 
Salmonella Typhimurium (PrgJ), 
B. thailandensis (BsaK) 
NAIP5/6  
Flagellins: 
Legionella pneumophila (FlaA), 
Salmonella Typhimurium (FliC), 
Y. pestis (FliC2), 
Photorhabdus luminescence (Fla),  
P. aeruginosa (FliC) 
AIM2  
Cytosolic DNA: 
Francisella tularensis, F. novocida,  
L. monocytogenes, P. gingivalis 
L. pneumophila ∆sdhA 
IFI16  
Non-bacterial cytosolic DNA: 
  Kasposi’s sarcoma-associated herpes virus 
PYRIN Rho modification 
Clostridium botulinum (C3),  
C. difficile (TcdB), Histophilus somni (lbpA),  




Y. enterocolitica, Y. pestis (YopJ) 
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6.2. Consequences of caspase-1 activation 
Major events after caspase-1 activation include (1) processing of biologically 
inactive pro-IL-1β (31 kDa) and pro-IL-18 (24 kDa) to the bioactive IL-1β (17 kDa) 
and IL-18 (18 kDa), (2) secretion of IL-1β, IL-18, and IL-1α (both pro-form and 
mature form), and (3) pyroptosis.  
IL-1β is a the major proinflammatory cytokine, and its activity is tightly 
controlled at multiple levels because of its pleiotropic functions in innate and 
adaptive immunity, metabolism, and bone homeostasis as well as inflammation 
[123]. Its transcription and translation is induced by the binding of PAMPs or 
DAMPs to pattern recognition receptors (PRRs). Then, the maturation of the pro-
form into the bioactive IL-1β and its secretion is executed by active caspase-1 
[124].  
Unlike IL-1β, pro-IL-18 is constitutively expressed in many cell types 
including monocytes and keratinocytes [125,126]. IL-18, in synergy with IL-12, 
induces IFN-γ, skewing helper T cell polarization toward Th1 cells [127]. 
Alternatively, stimulation of γδ T cells and CD4 T cells with IL-18 in the presence 
of IL-23 increases IL-17 production [128]. Pro-IL-1α is also constitutively 
expressed in nonhematopoietic cells while the expression is inducible in 
mononuclear phagocytes [129]. Although cleavage of pro-IL-1α to its mature 
protein is executed by calpain [130], both pro-IL-1α and IL-1α can be secreted 
upon caspase-1 activation or cell death, and they bind to IL-1 receptor 1 (IL-1R1) 
[131]. 
An additional consequence of caspase-1 is proinflammatory cell death, 
known as pyroptosis. Pyroptosis serves as an efficient bacterial clearance 
mechanism by preventing the intracellular replication of pathogens, releasing them 
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from infected cells and exposing them to killing by neutrophils [132]. 
Proinflammatory cytoplasmic contents released from dying cells and endogenous 
danger signals (such as HGMB1) secreted from caspase-1-activated cells alert and 
recruit other immune cells [133,134]. Therefore, caspase-1 plays an important role 
in eliminating the intracellular niche of pathogens in vivo. 
 
6.3. Inflammasome activation by P. gingivalis 
A few previous studies have shown that P. gingivalis activates caspase-1 or 
inflammasomes [121,135,136]. Taxman et al. [135] reported that P. gingivalis 
induces expression and secretion of IL-1β in an ASC- and caspase-1-dependent 
manner in human monocytes. It also has been reported that P. gingivalis and its 
LPS induce NLRP3- and ASC-dependent cell death in macrophages, which was not 
dependent on caspase-1 [136]. In addition, Park et al. [121] have shown that P. 
gingivalis infection of macrophages activates AIM2 and NLRP3 inflammasomes, 
leading to caspase-1 activation and pyroptosis and that ATP release, potassium 
efflux, and cathepsin B (a lysosomal enzyme) are involved in the activation of 
NLRP3 inflammasomes.  
Some previous studies, however, have shown that P. gingivalis fails to activate 
capase-1 activation [22,122,137]. A previous study reported that in macrophages, P. 
gingivalis does not activate caspase-1 and that it also blocks activation of NLRP3 
inflammasomes by other inducers like Fusobacterium nucleatum, monosodium 
urate, and alum, through inhibiting their endocytosis [122]. Another study showed 
that P. gingivalis inhibits ATP-mediated NLRP3 inflammasome and caspase-1 
activation in gingival epithelial cells by hydrolyzing ATP using its NDK [137]. In 
addition, P. gingivalis infection does not induce non-canonical caspase-1 activation 
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by cytosolic LPS because of its modified, immune-evasive LPS [22]. 
 
7. Aims of this study 
Recent studies on inflammasome and caspase-1 activation by P. gingivalis 
have shown inconsistent results [22,121,122,135-137], and the role of gingipains in 
caspase-1 activation by P. gingivalis infection has not yet been investigated. 
Because P. gingivalis and T. forsythia are frequently isolated together in 
periodontitis lesions [9,10], P. gingivalis may have an effect on phagocytosis and 
clearance of T. forsythia. The aims of this study were as follows:  
1) To elucidate the role of gingipains in caspase-1 activation by P. gingivalis in 
macrophages 
2) To investigate whether P. gingivalis, in particular via its gingipains, influences 












II. Materials and Methods 
1. Bacterial strains and growth conditions  
P. gingivalis (ATCC 33277, FDC 381, ATCC 49417, W50) and F. nucleatum 
ATCC 25586 were grown in brain heart infusion (BHI) broth supplemented with 
hemin (5 μg/mL) and vitamin K (1 μg/mL) under anaerobic conditions (10% CO2, 
10% H2, and 80% N2) at 37°C for 1 day. T. forsythia ATCC 43037 was grown in 
new oral spirochete broth (ATCC medium 1494) supplemented with vitamin K 
(0.02 μg/ml) and N-acetylmuramic acid (0.01 μg/ml) under the anaerobic condition 
at 37°C for 2 days.  
Gingipain mutants of P. gingivalis ATCC 33277 [KDP129 (kgp-), KDP133 
(rgpA- rgpB-), and KDP136 (kgp- rgpA- rgpB-)] were kindly provided by Dr Koji 
Nakayama of Nagasaki University, Nagasaki, Japan. The mutant strains were 
maintained in enriched BHI broth (37 g of BHI, 5 g of yeast extract, and 1 g of 
cysteine per liter) supplemented with hemin, vitamin K, and the following 
antibiotics as described previously [55]: chloramphenicol (20 μg/ml), erythromycin 
(10 μg/ml), and tetracycline (0.7 μg/ml).  
Where indicated, overnight cultures of P. gingivalis ATCC 33277 were washed 
with phosphate buffered saline (PBS) and preincubated in PBS containing 5 mM 
leupeptin (Sigma, St. Louis, MO, USA), 10 μM KYT-1 (Carbobenzoxy-Lys-Arg-
CO-Lys-N-(CH3)2, Peptide Institute, Osaka, Japan) or KYT-36 (Carbobenzoxy-
Glu(NHN(CH3)Ph)-Lys-CO-NHCH2Ph, Peptide Institute) under the anaerobic 





2. Treatment of P. gingivalis gingipain-null mutant with 
membrane vesicle-depleted culture supernatants 
For the experiments to examine the effect of processing by gingipains of 
surface proteins in P. gingivalis KDP136, membrane vesicle-depleted culture 
supernatants (VDS) of P. gingivalis ATCC 33277 and its gingipain mutant strains 
were prepared as described previously [58]. Culture supernatants of P. gingivalis 
after overnight culture were collected by centrifugation at 10,000 x g for 20 
minutes at 4°C, followed by filtration through 0.2-μm-pore-size filter (Minisart, 
Sartorius Stedim Biotech GmbH, Goettingen, Germany). The culture supernatants 
were depleted of membrane vesicles by ultracentrifugation at 100,000 x g for 50 
minutes at 4°C, and the obtained VDS were kept frozen at -80°C until use. 
The gingipain-null mutant KDP136 was cultured overnight in fresh culture 
medium containing 30% VDS of wild-type P. gingivalis or its gingipain mutants in 
the presence or absence of 10 μM KYT-1 or KYT-36. Because VDS of P. gingivalis 
contain several bacterial components as well as gingipains, gingipain-specific 
inhibitors KYT-1 and KYT-36 were used to determine whether the effect of VDS 
was attributable to gingipains. The overnight cultures of KDP136 were washed 
with PBS and used for infection. 
 
3. Cell cultures  
THP-1 cells (ATCC TIB-202), a human monocytic cell line, were cultured in 
RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS, Gibco BRL, 
Paisley, UK), 100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco BRL) in a 
humidified 5% CO2 atmosphere at 37°C.  
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Human peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll 
Paque (GE healthcare, Uppsala, Sweden) density gradient centrifugation from 
whole blood donated by healthy volunteers with the approval of Institutional 
Review Board of Seoul National University (IRB No. S-D20130004). The cells 
were then cultured in RPMI 1640 medium supplemented with 10% FBS, 100 U/ml 
penicillin, and 100 μg/ml streptomycin for 6 days. After adherent cells were 
detached using trypsin/EDTA (Gibco BRL), the cells were seeded into 6-well 
plates (2 x 106 cells/well) and cultivated for 24 hours before infection to investigate 
caspase-1 activation.  
To investigate phagocytosis in primary macrophages, CD14+ monocytes were 
isolated from PBMCs by positive selection using anti-human CD14 magnet 
particles with the BD IMag™ cell separation magnet (BD Biosciences, San Jose, 
CA, USA). To differentiate them into macrophages, the cells were cultured in 
RPMI 1640 medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 
μg/ml streptomycin in the presence of 10 μg/ml macrophage colony-stimulating 
factor (Peprotech, Princeton, NJ, USA) for 6 days. On the day before the 
phagocytosis assay, adherent cells were detached using trypsin/EDTA, seeded into 
24-well plates (5 x 105 cells/well), and further cultivated for 24 hours. 
 
4. Infection for caspase-1 activation  
THP-1 cells (2 x 106 cells/well in six-well plates) were differentiated into 
macrophage-like cells with 0.5 μM PMA for 3 hours. The differentiated cells or 
PBMC-derived macrophages were stimulated with the indicated MOI of live P. 
gingivalis, heat-killed P. gingivalis (95°C, 60 minutes), live F. nucleatum, or 0.5 
μg/ml Pam3CSK4 (InvivoGen, San Diego, CA, USA) for 6 hours unless otherwise 
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stated. For inhibition of P. gingivalis proteases during infection, wild-type P. 
gingivalis was preincubated in 0.2 or 5 mM leupeptin (Sigma, St. Louis, MO, 
USA)-containing PBS for 30 minutes, and THP-1 cells were infected with P. 
gingivalis in the presence of leupeptin at the indicated concentration. In 
experiments to examine the effects of caspase-1 inhibition, the cells were pre-
treated with the caspase-1 inhibitor Z-YVAD-FMK (Biovision, Palo Alto, CA, 
USA) or Ac-YVAD-CHO (Calbiochem, San Diego, CA, USA) at the indicated 
concentration for 30 minutes before stimulation with live or heat-killed P. 
gingivalis for 6 hours. Where indicated, THP-1 cells were preincubated with 300 
μM oxATP (Sigma), a P2X7 receptor antagonist, for 30 minutes and then infected 
with P. gingivalis for 6 hours.  
 
5. Immunoblotting 
After treatment of macrophages with P. gingivalis or other stimuli, the culture 
supernatants of the cells were collected, and the proteins in the culture supernatants 
were precipitated with 10% trichloroacetic acid (TCA, Sigma). After centrifugation 
at 16,000 x g for 10 minutes at 4°C, the protein pellets were neutralized using 0.1 
M NaOH. The cells were washed once with ice-cold DPBS and lysed with RIPA 
buffer [10 mM Tris (pH 7.5), 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM 
EDTA, 5 μM Na3VO4, 1 mM PMSF, and 1 x protease inhibitor cocktail (Roche, 
Manheim, Germany)] on ice with intermittent vortexing. The lysates were clarified 
by centrifugation at 16,000 x g for 45 minutes at 4°C. The protein concentration of 
the lysates was determined using the Bradford protein assay (Bio-Rad, Hercules, 
CA, USA). The TCA-precipitated supernatants and the cell lysates were mixed 
with sample buffer (supplemented with dithiothreitol) and heated at 95°C for 5 
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minutes for protein denaturation. The proteins were separated by SDS-PAGE (12%) 
and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, 
Billerica, MA, USA). Blots were incubated for 1 hour with blocking solution (Tris-
buffered saline [TBS] containing 0.1% Tween 20 and 5% bovine serum albumin or 
nonfat dried milk) and were probed with the following primary antibodies: rabbit 
polyclonal anti-caspase-1 from Cell Signaling Technology (Beverly, MA, USA), 
goat polyclonal anti-IL-1β from Santa Cruz Biotechnology (Santa Cruz, CA, USA), 
mouse monoclonal anti-actin from BD Biosciences, rabbit polyclonal anti-HMGB1 
from Millipore, and mouse monoclonal anti-NLRP3 and rabbit polyclonal anti-
ASC from AdipoGen (Liestal, Switzerland). The binding of the primary antibodies 
was visualized using horseradish peroxidase (HRP)-conjugated anti-rabbit IgG, 
anti-goat IgG, and anti-mouse IgG secondary antibodies (R&D systems, 
Minneapolis, MN, USA) and ECL Western blotting substrate (SUPEX, Dyne-Bio, 
Sungnam, Korea). β-Actin was used as a loading control. 
 
6. ELISA 
The concentration of IL-1β and IL-8 in the culture supernatants was measured 
using the Quantikine sandwich ELISA Kit (R&D Systems) according to the 
manufacturer’s instructions. 
 
7. Real-time reverse-transcription PCR 
Total RNA from THP-1 cells was isolated with an easy-BLUETM total 
extraction kit (iNtRON Biotechnology, Sungnam, Korea), and cDNA was 
synthesized using an M-MLV Reverse Transcriptase kit (Promega, Madison, WI, 
USA) and oligo dT primer (Cosmo GENETECH, Seoul, Korea). For real-time RT-
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PCR, cDNA was mixed with primer pairs (200 nM each) and 10 μl of 2X SYBR 
Premix Ex TaqTM (Takara Bio Inc., Otsu, Shiga, Japan) in a 20 μl reaction volume. 
Following initial denaturation at 95°C for 5 minutes, cDNA was amplified for 40 
cycles of denaturation (95°C, 15 sec), annealing (60°C, 15 sec), and extension 
(72°C, 33 sec) in an ABI PRISM 7500 Fast Real-Time PCR System (Applied 
biosystems, Foster City, CA, USA). Melting curve analysis of the PCR products 
was performed to ensure specificity of PCR amplification. Glyceraldehydes-3-
phosphate dehydrogenase (GAPDH) was used as a housekeeping control. The gene 
expression level was normalized against GAPDH and calculated by 2-∆∆CT method. 
The sequences of the forward and reverse primers (Cosmo GENETECH) used for 
the real-time PCR were 5’-AGCTGTACCCAGAGAGTCC-3’ and 5’-
ACCAAATGTGGCCGTGGTTT-3’, respectively for IL-1β, and 5’-
GTGGTGGACCTGACCTGC-3’ and 5’-TGAGCTTGACAAAGTGGTCG-3’, 
respectively for GAPDH. 
 
8. Measurement of cell death 
8.1. LDH cytotoxicity assay 
An increased lactate dehydrogenase (LDH) level in culture supernatant is a 
widely used marker for cell death because this cytoplasmic enzyme is rapidly 
released into extracellular space upon damage of the plasma membrane. THP-1 
cells (1 x 105 cells/100 μl in a 96-well plate) were differentiated and stimulated 
with live P. gingivalis, live F. nucleatum, or heat-killed P. gingivalis at the indicated 
MOI for 6 hours. The LDH levels in the culture supernatants of the THP-1 cells in 
triplicate wells were measured using an LDH cytotoxicity assay kit (Biovision) 
according to the manufacturer’s instructions. Relative amount of LDH (%) was 
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calculated as [(LDHSample – LDHControl) / (LDHMaximum – LDHControl) x 100]. For 
maximal LDH release (100%), cells were lysed with the lysis solution included in 
the kit.  
 
8.2. Propidium iodide exclusion assay 
Uptake of propidium iodide (PI), a membrane impermeant dye, was used as a 
marker for pore formation in the THP-1 cells, which is a sign of pyroptosis. To 
quantitate PI uptake, THP-1 cells were stained with 20 μM PI (Sigma) at 37°C for 
30 minute after the cells were infected with the indicated MOI of live P. gingivalis 
for 6 hours. The cells were then analyzed using flow cytometry (FACSCalibur, BD 
Biosciences) and Cell Quest Pro (BD Biosciences). The percentage of PI-positive 
cells was calculated.  
 
9. Protein degradation assay 
To assess whether P. gingivalis proteolytically degrades proteins that are 
released from caspase-1-activated cells, the culture supernatants of THP-1 cells that 
had been stimulated for 6 hours with heat-killed P. gingivalis equivalent to an MOI 
of 100 were used as substrates for the bacterial proteases. The culture supernatants, 
after filtration (0.2-μm-pore-size filter), were incubated with live P. gingivalis (1 x 
109 bacteria/ml or 2 x 108 bacteria/ml equivalent to an MOI of 500 or 100, 
respectively) for 1, 3, or 6 hours at 37°C. The culture supernatants were then 
analyzed by immunoblot analysis or LDH cytotoxicity assay. 
 
10. Intracellular caspase-1 activity assay 
After THP-1 cells were infected with P. gingivalis for 30 minutes or 2 hours, 
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the cells were detached using trypsin/EDTA. Active caspase-1 within the cells was 
stained using FAM-YVAD–FMK (FLICA™ Caspase-1 Assay Kit, 
Immunochemistry Technologies, Bloomington, MN, USA) at 37°C for 1 hour 
according to the manufacturer’s instructions. After washing with the wash buffer 
(included in the kit), the cells were fixed with the fixative (included in the kit). 
Intracellular active caspase-1 was then measured by flow cytometry (FACSCalibur), 
and the caspase-1 activity index was calculated as [(% positive cells x mean 
fluorescence intensity) / 100], which was adapted from a formula previously 
described for phagocytosis [101]. 
 
11. Determination of extracellular ATP concentrations 
After THP-1 cells were stimulated with the indicated MOI of live P. gingivalis 
for 50 minutes or 2 hours, the ATP concentration of the culture supernatants was 
determined using an ATP bioluminescence assay kit (Roche) according to the 
manufacturer’s instructions. ATP-degrading enzymes in culture supernatants were 
inactivated by incubating the culture supernatants with 0.3% TCA at 4°C for 30 
minutes. After mixing the supernatants with 4 volumes of 250 mM Tris acetate (pH 
7.75), the ATP assay reagents was added to the mixture as previously described 
[138]. The ATP levels in the culture supernatants were calculated after measuring 
the luminescence using GloMax® 96 Microplate Luminometer (Promega).  
 
12. Phagocytosis of T. forsythia 
THP-1 (5 x 105 cells/well) were seeded into 24-well plates and differentiated 
into macrophage-like cells with 0.1 μM PMA overnight. Differentiated THP-1 cells 
and PBMC-derived macrophages were infected with carboxyfluorescein diacetate 
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succinimidyl ester (CFSE, Molecular Probes, Eugene, OR, USA)-labelled T. 
forsythia in the presence or absence of unlabelled P. gingivalis at the indicated 
MOI for 1 hour. To examine the effect of gingipains of coinfecting P. gingivalis on 
phagocytosis of T. forsythia, wild-type and gingipain mutant strains of P. gingivalis 
were used. In experiments to examine phagocytosis of P. gingivalis, the cells were 
infected with CFSE-labelled P. gingivalis in the presence or absence of unlabelled 
T. forsythia at the indicated MOI for 1 hour. 
In experiments to examine the role of gingipain protease activities, overnight 
cultures of wild-type P. gingivalis were preincubated in PBS containing 10 μM 
KYT-1 or KYT-36 under anaerobic conditions at 37°C for 1 hour. After washing 
with PBS, P. gingivalis were used for mixed infection with CFSE-labelled T. 
forsythia. 
In experiments examining the effect of gingipains on T. forsythia, CFSE-
labelled T. forsythia was preincubated in fresh culture medium containing 30% 
VDS of wild-type P. gingivalis or gingipain mutant strains in the presence or 
absence of 10 μM KYT-1 or KYT-36 for 1 hour. After washing with PBS, T. 
forsythia was used for infection.  
In experiments to examine the effect of gingipains on macrophages, THP-1 
cells were preincubated with P. gingivalis VDS (equivalent to an MOI of 100) for 1 
hour in the presence or absence of 10 μM KYT-1 or KYT-36. The cells were then 
infected for 1 hour with CFSE-labelled T. forsythia in the presence or absence of P. 
gingivalis VDS and gingipain inhibitors. 
Infected cells were detached with trypsin/EDTA, and the fluorescence 
intensity of the cells was analyzed by flow cytometry (FACSCalibur). To measure 
the internalization of T. forsythia, the cells were analyzed after quenching 
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extracellular fluorescence from adherent bacteria with 400 μg/ml trypan blue.  
 
13. Intracellular persistence 
THP-1 cells were infected with CFSE-labelled T. forsythia in the presence or 
absence of unlabelled P. gingivalis at an MOI of 100 for 1 hour. The infected cells 
were washed twice with PBS and incubated in media containing 300 μg/ml 
gentamicin (Sigma) and 200 μg/ml metronidazole (Sigma) for 1 hour to kill 
extracellular bacteria. The cells were then washed twice with PBS and further 
incubated in culture media for 0, 6, 12, 24, or 48 hours. At each time point, the 
cells were detached with trypsin/EDTA, and the fluorescence intensity of the cells 
was analyzed via flow cytometry after quenching the extracellular fluorescence 
from adherent bacteria with 400 μg/ml trypan blue. 
 
14. Confocal microscopy 
THP-1 cells (2 x 105 cells/well on coverslips in 24-well plates) were 
differentiated and infected with CFSE-labelled T. forsythia in the presence or 
absence of unlabelled P. gingivalis at an MOI of 100 for 1 hour. The infected cells 
were washed twice with PBS and fixed with 4% paraformaldehyde. The cells were 
stained with rhodamine phalloidin (Sigma) to visualize actin cytoskeleton and with 
Hoechst 33342 (Molecular Probes) to counterstain nuclei. The cells were observed 
under a confocal laser scanning microscope (LSM 700, Carl Zeiss, Jena, Germany). 
In experiments to examine the persistence of T. forsythia in the infected 
macrophages, the cells were washed twice with PBS after 1 hour of infection. The 
cells were incubated in media containing 300 μg/ml gentamicin and 200 μg/ml 
metronidazole for 1 hour to kill extracellular bacteria, followed by further 
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incubation in media for 24 or 48 h. The cells were then washed twice with PBS and 
examined by confocal microscopy after fixation and staining as described above.  
 To examine phagosomal maturation, THP-1 cells (2 x 105 cells/well on 
coverslips in 24-well plates) were differentiated and infected with CFSE-labelled P. 
gingivalis or CFSE-labelled T. forsythia in the presence or absence of unlabelled P. 
gingivalis at an MOI of 100 for 1 or 3 hours. The cells were then stained with 50 
nM LysoTracker Red (Molecular Probes) for 30 minutes. The cells were then 
washed twice with PBS and examined by confocal microscopy after fixation and 
staining as described above. 
 
15. Coaggregation assay 
The coaggregation activity between T. forsythia and P. gingivalis was 
quantitated as decrease in optical density at 660 nm (OD660) as previously 
described [67] with slight modifications. Bacteria were harvested at 10,000 x g for 
3 minutes at 4°C and washed with coaggregation buffer (0.1 mM CaCl2, 0.1 mM 
MgCl2, 0.15 M NaCl, 3.1 mM NaN3, and 1 mM Tris, pH 8.0). After the bacteria 
were resuspended in coaggregation buffer at 5 x 109 bacteria/ml, equal volumes 
(500 μl) of each bacterial suspension were mixed, and the initial OD660 of the 
mixtures was measured. To allow coaggregation of the two bacterial species, the 
mixtures were then left to stand for 90 minutes at room temperature, and the OD660 
was measured. The precipitation of bacterial aggregates to the bottom of the tubes 
resulted in decreases in the optical density. The percent coaggregation was 
calculated as [(initial OD660 – OD660 at 90 minutes) / initial OD660 x 100]. To 
examine the effects of particular amino acids on coaggregation, L-arginine (Sigma), 
L-lysine (Sigma), histidine (Difco, Detroit, MI, USA), or glycine (Duchefa, 
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Haarlem, The Netherlands) was added to the bacterial mixtures at the indicated 
concentration.  
 
16. RNA-based viability assay of intracellular T. forsythia 
Viability of intracellular T. forsythia was assessed by analyzing T. forsythia 
16S rRNA within infected cells as previously described [139]. THP-1 cells were 
infected with T. forsythia in the presence or absence of P. gingivalis at an MOI of 
100 for 1 hour. The infected cells were washed twice with PBS and incubated in 
media containing 300 μg/ml gentamicin and 200 μg/ml metronidazole for 1 hour to 
kill extracellular bacteria. The cells were then washed twice with PBS and further 
incubated in culture media for 0, 24, or 48 hours. At each time point, total RNA 
from THP-1 cells was isolated with an easy-BLUETM total extraction kit, and 
cDNA was synthesized using an M-MLV Reverse Transcriptase kit and random 
primer (Promega). For real-time RT-PCR of T. forsythia 16S rRNA and human 
GAPDH, an equal amount of cDNA was mixed with primer pairs (50 nM each) and 
10 μl of 2X Power SYBR® Green Master mix (Applied Biosystems) in a 20 μl 
reaction volume. Following initial denaturation at 95°C for 10 minutes, cDNA was 
amplified for 40 cycles of denaturation (95°C, 15 sec) and annealing/extension 
(57°C, 60 sec) in an ABI PRISM 7500 Fast Real-Time PCR System. Melting curve 
analysis of the PCR products was performed to ensure specificity of PCR 
amplification. The sequences of the forward and reverse primers (Cosmo 
GENETECH) used for real-time PCR of T. forsythia 16S rRNA were 5’-
ATTGAAATGTAGACGACGGAGAGT-3’ and 5’-TTACCTGTTAGCAACTG 
ACAGTCA-3’, respectively. For real-time RT-PCR of human GAPDH, the primer 
pairs described earlier were used. The relative amount of live bacteria in host cells 
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was calculated by normalizing the amount of T. forsythia 16S rRNA against 
GAPDH mRNA in host cells by 2-∆∆CT method. 
 
17. Statistical analysis 
A standard two-tailed t test was used for statistical analysis, and values of P < 























1. Role of gingipains in caspase-1 activation  
1.1 Low IL-1β and LDH levels without active caspase-1 in the culture 
supernatants at low MOIs are abrogated by high MOIs of P. gingivalis 
infection 
Active caspase-1 (a tetramer of p20 and p10) is secreted into the extracellular 
space upon caspase-1 activation. Thus, the presence of the p20 or p10 subunits of 
active caspase-1 in culture supernatant is considered a sign of caspase-1 activation. 
When THP-1 cells were infected with live P. gingivalis ATCC 33277 at MOIs of 10, 
50, 100, or 500, the subunit of active caspase-1(p20) was not detected in the culture 
supernatant of the P. gingivalis-infected cells (Fig. 3A), although mature IL-1β was 
slightly increased at low MOIs (Fig. 3A and B). In addition, high MOIs of P. 
gingivalis abolished IL-1β secretion in the culture supernatant although P. 
gingivalis induced the expression of pro-IL-1β mRNA in an MOI-dependent 
manner (Fig. 3B). As a positive control, it was shown that active caspase-1 (p20) 
and mature IL-1β were detected after infection with live F. nucleatum, a 
periodontopathogen known to activate the NLRP3 and AIM2 inflammasome [122]. 
The level of LDH in the culture supernatants, a commonly used marker of cell 
death, showed a similar pattern to that of mature IL-1β (Fig. 4A). However, when 
pore formation, another sign of pyroptosis, was assessed using a PI exclusion assay, 
it was found that P. gingivalis apparently induced the uptake of the membrane-








Figure 3. P. gingivalis induces minimal levels of IL-1β without active caspase-1 
in culture supernatant. THP-1 cells were infected with live P. gingivalis at the 
indicated MOI for 6 hours. (A) Immunoblot analysis was performed to detect 
caspase-1 and IL-1β in the culture supernatants (sup) and pro-caspase-1, pro-IL-1β, 
and β-actin in the cell lysates (cell). (B) The concentration of IL-1β in the culture 
supernatants was determined by ELISA, and mRNA expression of pro-IL-1β was 
analyzed using real-time RT-PCR and was normalized to that of GAPDH. The 
experiments were performed three times, and the representative data are shown as 
the mean ± standard deviation. Pg, P. gingivalis; Fn, F. nucleatum. * P < 0.05 















Figure 4. P. gingivalis induces pore formation with minimal levels of LDH in 
culture supernatant. THP-1 cells were infected with live P. gingivalis at the 
indicated MOI for 6 hours. (A) The levels of the cytoplasmic enzyme LDH in the 
culture supernatants were evaluated using the LDH cytotoxicity assay kit. (B) 
Propidium iodide (PI) uptake of the infected cells was analyzed using flow 
cytometry. The experiments were performed three times, and the representative 
data are shown as the mean ± standard deviation. Pg, P. gingivalis; Fn, F. 





P. gingivalis–infected THP-1 cells were pulsed with ATP because it has been 
reported that P. gingivalis induces IL-1β secretion with the addition of exogenous 
ATP [122,140]. ATP is released from intracellular storage following cell distress, 
damage, or death, resulting in an elevation of extracellular ATP concentrations. The 
activation of the P2X7 receptor by high extracellular ATP concentrations leads to 
the activation of NLRP3 inflammasome and caspase-1 [141]. However, a pulse 
with ATP after P. gingivalis infection did not lead to the detection of active 
caspase-1 (p20) in the culture supernatants, although it slightly increased the IL-1β 
levels (Fig. 5A). In addition, P. gingivalis significantly induced ATP release from 
the infected cells in an MOI-dependent manner (Fig. 5B). The opposite regulation 
of pro-IL-1β mRNA expression and IL-1β secretion, the contrasting results for the 
PI uptake and LDH release, and the abrogation of caspase-1 detection induced by 























Figure 5. The absence of active caspase-1 is not due to lack of ATP release. (A) 
THP-1 cells were infected with live P. gingivalis at the indicated MOI for 6 hours 
and pulsed with 2.5 mM ATP for 30 minutes. The levels of caspase-1 and IL-1β in 
the culture supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell 
lysates (cell) were analyzed by immunoblot analysis. (B) After THP-1 cells were 
infected with live P. gingivalis for 2 hours, the extracellular ATP concentration was 
measured using an ATP bioluminescence assay kit. The experiments were 
performed twice, and the representative data are shown as the mean ± standard 





1.2. Low levels of IL-1β result from the potent proteolytic activity of P. 
gingivalis 
To determine whether P. gingivalis has the potential to activate caspase-1, 
heat-killed bacteria was used to inactivate its proteases. After stimulation with heat-
killed bacteria, THP-1 cells released significant amounts of active caspase-1 (p20) 
and IL-1β (Fig. 6A and B) as well as LDH (Fig. 6C) in a dose-dependent manner. 
Pre-treatment of the cells with the caspase-1 inhibitors z-YVAD-FMK and Ac-
YVAD-CHO completely blocked IL-1β secretion (Fig. 6D), indicating that the 
maturation of IL-1β induced by heat-killed P. gingivalis is caspase-1-dependent. 
These results suggest that some heat labile components of P. gingivalis, possibly 
proteases, are responsible for the reduced levels of caspase-1, IL-1β, and LDH in 
the culture supernatants.  
To confirm that P. gingivalis degrades the signature proteins of caspase-1 
activation in the culture supernatants, culture supernatants of THP-1 cells that had 
been stimulated with heat-killed P. gingivalis were used as substrates for the 
bacterial proteases. The active caspase-1 (p20) and the mature IL-1β (p17) 
disappeared completely within 1 and 6 hours, respectively, of incubation with 1 x 
109 bacteria/ml P. gingivalis (Fig. 7A). A smaller fragment of IL-1β was detected as 
a result of partial proteolysis. Likewise, most LDH in the culture supernatants was 
lost within 1 hour of incubation with P. gingivalis (Fig. 7B). Leupeptin, a cysteine 
protease inhibitor, was used for limiting proteolysis by the proteases of P. 
gingivalis. Preincubation of P. gingivalis with leupeptin was insufficient to prevent 
the degradation of IL-1β for 6 hours (Fig. 7C). In addition, neither caspase-1 nor 
IL-1β was detected in the culture supernatants after infection of THP-1 cells with 
leupeptin-preincubated P. gingivalis (Fig. 7D), indicating that P. gingivalis restored 
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its proteolytic ability within a few hours.  
When THP-1 cells were infected in the presence of leupeptin with live P. 
gingivalis that had been preincubated with leupeptin. P. gingivalis evidently 
resulted in caspase-1 activation and IL-1β secretion (Fig. 8A and B). The level of 
LDH released from the macrophages after infection with live P. gingivalis was also 
significantly increased in the presence of leupeptin (Fig. 8C). Because P. gingivalis 
strains have different proteolytic activity, other strains of P. gingivalis, FDC 381, 
ATCC 49417, and W50 were used to determine whether this phenomenon is a 
common characteristic of P. gingivalis (Fig. 9A). Active caspase-1 was not detected 
in the culture supernatants of cells infected with any P. gingivalis strains at an MOI 
of 100. Infection with P. gingivalis ATCC 49417 and W50, which are known to be 
more virulent and genetically distant from P. gingivalis ATCC 33277 [25], resulted 
in a considerable amount of IL-1β in the culture supernatants. However, infection 
with a higher MOI (500) of the two strains lowered or abrogated the IL-1β levels, 
while the presence of leupeptin during infection led to an increase in the caspase-1 
and IL-1β levels (Fig. 9B). These results indicate that the proteolytic depletion of 












Figure 6. Heat-killed P. gingivalis induces caspase-1-dependent IL-1β secretion. 
(A-C) THP-1 cells were stimulated with heat-killed P. gingivalis at the indicated 
MOI for 6 hours. (A) The levels of caspase-1 and IL-1β in the culture supernatants 
(sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell lysates (cell) were 
analyzed by immunoblot analysis. (B) The concentration of IL-1β in the culture 
supernatants was determined by ELISA. (C) The levels of LDH in the culture 
supernatants were evaluated with the LDH cytotoxicity assay kit. (D) THP-1 cells 
were pre-treated with the caspase-1 inhibitor Z-YVAD-FMK or Ac-YVAD-CHO 
for 30 minutes before 6 hours of stimulation with heat-killed P. gingivalis. 
Immunoblot analysis was performed to detect IL-1β in the culture supernatants 
(sup) as well as pro-IL-1β and β-actin in the cell lysates (cell). The experiments 
were performed three times, and the representative data are shown as the mean ± 
standard deviation. * P < 0.05 compared to the control. hPg, heat-killed P. 




Figure 7. Live P. gingivalis proteolytically degrades caspase-1, IL-1β, and LDH. 
(A, B) Live P. gingivalis (1 x 109 cfu/ml equivalent to an MOI of 500) was 
incubated for the indicated time in the culture supernatants of THP-1 cells that had 
been stimulated with heat-killed P. gingivalis. The amounts of remaining active 
caspase-1 (p20) and IL-1β were determined by immunoblot analysis (A), and those 
of LDH were analyzed using an LDH cytotoxicity assay (B). * P < 0.05 compared 
to 0 h. (C) Live P. gingivalis was preincubated with 0.2 mM leupeptin, a cysteine 
protease inhibitor, for 1 hour and then incubated in the presence or absence of 
leupeptin (at the indicated concentration) for 6 hours with the culture supernatants 
of THP-1 cells that had been stimulated with heat-killed P. gingivalis. The amounts 
of remaining IL-1β in the culture supernatants were determined by ELISA. The 
experiments were performed twice, and the representative data are shown as the 
mean ± standard deviation. * P < 0.05 compared to P. gingivalis without 
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preincubation with leupeptin. (D) THP-1 cells were infected in the absence of 
leupeptin for 6 hours with P. gingivalis that had been preincubated with 5 mM 
leupeptin. Immunoblot analysis was performed to detect caspase-1 and IL-1β in the 
culture supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell 

























Figure 8. Live P. gingivalis induces secretion of caspase-1 and IL-1β as well as 
release of LDH in the presence of leupeptin. THP-1 cells were infected with P. 
gingivalis for 6 hours in the presence or absence of leupeptin. (A) Immunoblot 
analysis was performed to detect caspase-1 and IL-1β in the culture supernatants 
(sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell lysates (cell). (B) The 
concentration of IL-1β in the culture supernatants was determined by ELISA. (C) 
The levels of LDH in the culture supernatants were evaluated using the LDH 
cytotoxicity assay. The experiments were performed three times, and the 
representative data are shown as the mean ± standard deviation. * P < 0.05 
compared to the control; ** P < 0.05 compared to the control containing 5 mM 













Figure 9. Proteolysis of secreted caspase-1 and IL-1β is a common feature of P. 
gingivalis infection. (A) THP-1 cells were infected with live P. gingivalis ATCC 
33277, FDC 381, ATCC 49417, or W50 at an MOI of 100 for 6 hours. (B) THP-1 
cells were infected with live P. gingivalis ATCC 49417 or W50 at an MOI of 500 in 
the presence or absence of leupeptin for 6 hours. The resulting levels of caspase-1 
and IL-1β in the culture supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-
actin in the cell lysates (cell) were analyzed by immunoblot analysis. Pg, P. 




1.3. Rgps and Kgp of P. gingivalis wipe out caspase-1-dependent proteinaceous 
responses 
Next, the roles of gingipains, the major cysteine proteases of P. gingivalis, in 
caspase-1 activation were investigated using gingipain mutant strains. Unlike wild-
type P. gingivalis (ATCC 33277), infection with a P. gingivalis mutant strain 
lacking both Kgp and Rgps (KDP136) led to a substantial amount of active 
caspase-1 and IL-1β in the culture supernatants of both the THP-1 cells and the 
PBMC-derived macrophages (Fig. 10A and B). The levels of active caspase-1 and 
IL-1β induced by the mutant strain were comparable to those induced by heat-
killed wild-type P. gingivalis. The mutant strains that lack either Kgp (KDP129) or 
Rgps (KDP133) induced lower IL-1β levels than KDP136, with either a low level 
or no detectable caspase-1 in the culture supernatants (Fig. 10A and B). 
Unexpectedly, KDP136 induced lower levels of LDH release from the infected 
cells than those induced by KDP129 and KDP133, while infection with wild-type P. 
gingivalis resulted in the lowest level of LDH in the culture supernatants (Fig. 10C). 
In the presence of leupeptin, which preserved IL-1β in the culture supernatants (Fig. 
11A), the pre-treatment of the cells with the caspase-1 inhibitor Ac-YVAD-CHO 
significantly reduced the IL-1β secretion induced by P. gingivalis, regardless of the 
presence of a gingipain mutation (Fig. 11B) whereas secretion of IL-8, which is not 
dependent on caspase-1 activation, was not affected by the inhibitor (Fig. 11C). 
These results indicate that the maturation of IL-1β induced by live P. gingivalis is 
caspase-1-dependent. 
To determine the role of each gingipain in the degradation of the signature 
proteins of caspase-1 activation, wild-type P. gingivalis and gingipain mutants were 
incubated in the culture supernatants of THP-1 cells that had been stimulated with 
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heat-killed P. gingivalis. The proteolytic depletion of IL-1β and LDH seems to be 
accelerated by the cooperative action of Rgps and Kgp, as their degradation by 
wild-type P. gingivalis was much faster than by KDP129 or KDP133 (Fig. 12A and 
B). An IL-1β fragment of a smaller size (approximately 15-16 kDa) was detected 
after incubation with wild-type or KDP129, indicating that Rgps result in the 
partial proteolysis of IL-1β. It was determined whether other proteins that are 
released from cells with caspase-1 activation and can augment inflammation were 
also degraded. HMGB1 is a DAMP that is released after caspase-1 activation and 
binds RAGE, TLR2, and TLR4 [142]. HMGB1 in the culture supernatants was also 
more rapidly decreased by the wild-type P. gingivalis than by the gingipain mutant 
strains (Fig. 12A), suggesting a combined action of Kgp and Rgps. Recent studies 
have reported that upon caspase-1 activation, inflammasome particles or ASC 
specks are released into the extracellular space and continue to process pro-
caspase-1 and pro-IL-1β [143,144]. In addition, the released particles and specks 
amplify the inflammatory response by acting as particulate danger signals 
[143,144]. By degrading inflammasome components such as NLRP3, ASC, and 
pro-caspase-1 in the culture supernatants (Fig. 12A), P. gingivalis gingipains may 
stop the propagation of inflammation. Their degradation pattern was similar to 
HMGB1, while pro-IL-1β was degraded comparably by the gingipain-expressing 









Figure 10. The secretion of caspase-1 and IL-1β is cooperatively diminished by 
Rgps and Kgp. (A) THP-1 cells or PBMC-derived macrophages were infected 
with wild-type P. gingivalis or gingipain mutant strains KDP129, 133, or 136 at an 
MOI of 100 or 500 for 6 hours. The levels of caspase-1 and IL-1β in the culture 
supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell lysates (cell) 
were analyzed by immunoblot analysis. (B) The concentration of IL-1β in the 
culture supernatants of THP-1 cells was determined by ELISA. (C) The levels of 
LDH in the culture supernatants of the THP-1 cells were evaluated with the LDH 
cytotoxicity assay kit. The experiments were performed three times, and the 
representative data are shown as the mean ± standard deviation. * P < 0.05 
compared to the control in the MOI of 100 set; # P < 0.05 compared to the control 
in the MOI of 500 set. WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, 
KDP133 (rgpA- rgpB-); 136, KDP136 (kgp- rgpA- rgpB-); hPg, heat-killed P. 




Figure 11. IL-1β secretion induced by live P. gingivalis is caspase-1-dependent. 
(A) THP-1 cells were infected with wild-type P. gingivalis or gingipain mutants for 
6 hours in the absence or presence of leupeptin. The resulting levels of caspase-1 
and IL-1β in the culture supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-
actin in the cell lysates (cell) were analyzed by immunoblot analysis. (B, C) THP-1 
cells were pre-treated with 50 μM Ac-YVAD-CHO for 30 minute and then 
stimulated with wild-type P. gingivalis or gingipain mutant strains at an MOI of 
100 in the presence of leupeptin for 6 hours. The concentration of IL-1β (B) and 
IL-8 (C) in the culture supernatants was assessed by ELISA. # P < 0.05 compared 
between two groups. WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, 




Figure 12. Rgps and Kgp cooperatively degrade the released proteins 
including inflammasome components. Wild-type P. gingivalis and gingipain 
mutants (2 x 108 cfu/ml equivalent to an MOI of 100) were incubated for the 
indicated time in the culture supernatants of THP-1 cells that had been stimulated 
with heat-killed P. gingivalis. (A) Immunoblot analysis was performed on the 
culture supernatants to determine the amounts of remaining caspase-1 (p20), IL-1β, 
and HMGB1 as well as inflammasome components including NLRP3, ASC, pro-
caspase-1, and pro-IL-1β. (B) The loss of LDH in the culture supernatants was 
determined using an LDH cytotoxicity assay kit. * P < 0.05 compared to the group 
without Pg. Pg, P. gingivalis; WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 





1.4. Gingipains differentially enhance caspase-1 activation by promoting ATP 
release 
To investigate the role of gingipains in caspase-1 activation, an assessment 
that is not affected by the proteolytic depletion was used to determine caspase-1 
activity in the infected macrophages. After infection with P. gingivalis at an MOI of 
100 for 30 minutes or 2 hours, the active caspase-1 in the cells was stained with 
FAM-YVAD-FMK and analyzed by flow cytometry. Caspase-1 activity was higher 
after 30 minutes of P. gingivalis infection than after 2 hours of infection (Fig. 13A), 
which resulted from the rapid secretion of caspase-1 upon its activation. Both at 30 
minutes and at 2 hours of infection, the gingipain-null mutant KDP136 induced the 
lowest level of intracellular caspase-1 activity, which did not result from more 
secretion of caspase-1 (Fig. 13B). P. gingivalis wild-type and KDP133 with Kgp 
induced similar levels of caspase-1 activation, while KDP129 with Rgps showed 
the highest caspase-1-activating potential (Fig. 13A). This result suggests that 
gingipains enhance the caspase-1-activating potential of P. gingivalis. In particular, 
the presence of Rgps seems to promote caspase-1 activation more effectively than 
the presence of both Rgps and Kgp. 
To examine whether the gingipains affect ATP release from the infected THP-
1 cells, the ATP concentration in the culture supernatants was measured. P. 
gingivalis wild-type, KDP129, and KDP133 induced more ATP release from the 
infected cells than that induced by the gingipain-null KDP136 (Fig. 14A). In 
addition, infection with KDP129 led to higher levels of ATP release than infection 
with the wild-type strain. Because of similar trends between caspase-1 activity and 
ATP release (Fig. 13A and 14A), it was examined whether the modulation of 
caspase-1 activity by gingipains is mediated by ATP release. Pre-treatment of THP-
53 
 
1 cells with oxATP, a P2X7 receptor antagonist, before P. gingivalis infection 
significantly reduced the caspase-1 activity (Fig. 14B) and IL-1β secretion (Fig. 
14C) in cells infected with wild-type P. gingivalis, KDP129, and KDP133. The 
decrease in active caspase-1 (p20) in the culture supernatants was not evident due 
to its low levels caused by the proteolytic depletion. Inhibition of caspase-1 
activation and IL-1β secretion by oxATP in the KDP136-infected cells was also 
observed (Fig. 14C), although the decrease in caspase-1 activity caused by oxATP 
was minimal after 30 minutes of infection (Fig. 14B). This result might be 
attributed to low levels of ATP release and caspase-1 activation, and addition of 
exogenous ATP further increased activation of caspase-1 in the KDP136-infected 
cells (Fig. 15A and B). These results suggest that P. gingivalis gingipains affect 























Figure 13. Gingipains differentially enhance caspase-1 activation in P. 
gingivalis infection. THP-1 cells were infected with wild-type P. gingivalis or 
gingipain mutants at an MOI of 100 for the indicated time. (A) The caspase-1 
activity was quantified using a Caspase-1 assay kit and flow cytometry. (B) The 
levels of caspase-1 and IL-1β in the culture supernatants (sup) and pro-caspase-1, 
pro-IL-1β, and β-actin in the cell lysates (cell) were analyzed by immunoblot 
analysis. The experiments were performed twice, and the representative data are 
shown as the mean ± standard deviation. * P < 0.05 compared to the control; # P < 
0.05 compared between two groups. WT, P. gingivalis ATCC 33277; 129, KDP129 





Figure 14. P. gingivalis gingipains modulate caspase-1 activation by affecting 
ATP release. (A) THP-1 cells were infected with wild-type P. gingivalis or 
gingipain mutants at an MOI of 100 for 50 minutes, and the extracellular ATP 
concentration was measured using an ATP bioluminescence assay kit. (B, C) THP-
1 cells were preincubated with 300 μM oxATP, a P2X7 receptor antagonist, for 30 
minutes before infection with P. gingivalis. (B) Caspase-1 activity was quantified 
after 30 minutes of infection using Caspase-1 assay kit and flow cytometry. (C) 
After 6 hours of infection, the levels of caspase-1 and IL-1β in the culture 
supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-actin in the cell lysates (cell) 
were analyzed by immunoblot analysis. The experiments were performed twice, 
and the representative data are shown as the mean ± standard deviation. * P < 0.05 
compared to the control; # P < 0.05 compared between two groups. WT, P. 
gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 (rgpA- rgpB-); 136, 







Figure 15. Exogenous ATP augments caspase-1 activation in KDP136-infected 
cells. THP-1 cells were infected with P. gingivalis KDP136 at an MOI of 100 for 
the indicated time and pulsed with 2.5 mM ATP for 15 minutes. (A) The caspase-1 
activity was quantified using a Caspase-1 assay kit and flow cytometry. (B) The 
levels of caspase-1 and IL-1β in the culture supernatants (sup) and pro-caspase-1, 
pro-IL-1β, and β-actin in the cell lysates (cell) were analyzed by immunoblot 
analysis. # P < 0.05 compared between two groups. Pg, P. gingivalis; 136, KDP136 




1.5. Gingipains indirectly facilitate caspase-1 activation in infected cells, 
possibly by processing the surface proteins of P. gingivalis 
Because gingipains are important processing enzymes for multiple bacterial 
surface proteins such as major and minor fimbriae, hemoglobin receptors, and 
proteases including the gingipains themselves, the gingipain mutants have defects 
in these proteins [51,56]. Thus, the difference in caspase-1-activating potential 
among wild-type P. gingivalis and gingipain mutants may be attributable to 
differences in the processing and maturation of the surface proteins. A previous 
study demonstrated that soluble gingipains in membrane vesicle-depleted culture 
supernatants (VDS) can successfully generate an outer membrane protein in 
KDP136, which inherently lacks the mature form on the bacterial surface [58]. To 
examine how the processing of surface proteins by gingipains affects caspase-1 
activation, the gingipain-null mutant KDP136 was grown in culture medium 
containing the VDS of KDP129, KDP133, or wild-type in the presence or absence 
of KYT-1 and KYT36 for Rgps and Kgp inhibition, respectively (Fig. 16A). 
KDP136 grown in VDS containing Rgps (of KDP129), Kgp (of KDP133), or both 
(of wild-type) induced more caspase-1 activation (Fig. 16B), IL-1β secretion (Fig. 
16B and C), and LDH release (Fig. 16D) than that grown in VDS containing no 
gingipains (of KDP136). The observed enhancement was reversed by the presence 
of gingipain inhibitors. These results indicate that the protease activities of 
gingipains indirectly contribute to the caspase-1-activating potential of P. gingivalis, 
possibly by processing bacterial surface proteins, although changes in the surface 








Figure 16. Treatment of gingipain-null mutant with exogenous gingipains 
enhances its ability to activate caspase-1. (A) The gingipain-null KDP136 was 
grown overnight in the bacterial culture media containing 30% membrane vesicle-
depleted supernatants (VDS) of P. gingivalis gingipain mutants or wild-type with 
or without 10 μM KYT-1 (for Rgp inhibition), KYT-36 (for Kgp inhibition), or 
with both. THP-1 cells were then infected with the KDP136 at an MOI of 100 for 6 
hours. (B) The levels of caspase-1 and IL-1β in the culture supernatants (sup) and 
pro-caspase-1, pro-IL-1β, and β-actin in the cell lysates (cell) were analyzed by 
immunoblot analysis. (C) The concentration of IL-1β in the culture supernatants 
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was determined by ELISA. (D) The levels of LDH in the culture supernatants were 
measured using the LDH cytotoxicity assay. * P < 0.05 compared to the group of 
KDP136 preincubated with VDS of KDP136; # P < 0.05 compared between two 
groups. WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 (rgpA- 























1.6. Protease activity of gingipains impairs extracellular ATP release and 
caspase-1 activation 
To examine the role of gingipain protease activity during the infection process 
in the modulation of ATP release and caspase-1 activation in the infected THP-1 
cells, wild-type P. gingivalis was preincubated with KYT-36 for Kgp inhibition or 
KYT-1 for Rgp inhibition shortly before infection. The inhibition of Kgp 
significantly increased ATP release from P. gingivalis-infected THP-1 cells. Rgp-
inhibited P. gingivalis also enhanced ATP release although the increase was less 
than that following Kgp inhibition (Fig. 17A). Unexpectedly, unlike the gingipain-
null KDP136 (Fig. 13A), the inhibition of both Kgp and Rgps significantly 
increased ATP release (Fig. 17A). The difference might be attributable to the fact 
that although the protease activity of gingipains is absent or inhibited in both the 
gingipain-null mutant and the gingipains-inhibited wild-type P. gingivalis, the 
former does not have other features of gingipains such as adhesin domains and 
processing of bacterial proteins, whereas the latter has them. The inhibition of 
either or both gingipains led to enhanced caspase-1 activity in the infected THP-1 
cells in a similar manner to the ATP release (Fig. 17B). Pre-treatment of THP-1 
cells with oxATP before P. gingivalis infection significantly inhibited caspase-1 
activity (Fig. 17B) and IL-1β secretion (Fig. 17C) that were enhanced by gingipain 
inhibition. These results indicate that the simultaneous proteolytic action of Kgp 
and Rgps during infection makes P. gingivalis induce less ATP release and caspase-
1 activation. In addition, the high caspase-1-activating potential of the wild-type 
with both Kgp and Rgp inhibition compared to KDP136 supports the idea that 
some functions of Kgp and Rgps, other than direct protease activity during 




Figure 17. Inhibition of the protease activity of gingipains increases caspase-1 
activation by augmenting ATP release. (A) Wild-type P. gingivalis was 
preincubated with 10 μM KYT-36 or KYT-1 for 1 hour to inhibit Kgp or Rgps, 
respectively. THP-1 cells were then infected with the wild-type P. gingivalis at an 
MOI of 100. The extracellular ATP concentration after 50 minutes of P. gingivalis 
infection was measured using an ATP bioluminescence assay kit. The experiments 
were performed twice, and the representative data are shown as the mean ± 
standard deviation. * P < 0.05 compared to the control; # P < 0.05 compared 
between two groups. (B, C) THP-1 cells were preincubated with 300 μM oxATP 
for 30 minutes before infection with P. gingivalis that had been preincubated with 
10 μM KYT-36 or KYT-1 for 1 hour. (B) After 30 minutes of infection, caspase-1 
activity was assessed using a Caspase-1 assay kit and flow cytometry. The 
experiments were performed twice, and the representative data are shown as the 
mean ± standard deviation. * P < 0.05 compared to WT; # P < 0.05 compared 
between two groups. (C) After 6 hours of infection, the levels of caspase-1 and IL-
1β in the culture supernatants (sup) and pro-caspase-1, pro-IL-1β, and β-actin in 
the cell lysates (cell) were analyzed by immunoblot analysis. WT, P. gingivalis 
ATCC 33277.  
62 
 
2. Role of gingipains in augmentation of T. forsythia 
phagocytosis  
2.1. Phagocytosis of T. forsythia is facilitated by coinfection with P. gingivalis 
To determine whether P. gingivalis coinfection influences phagocytosis of T. 
forsythia, THP-1 cells were infected with CFSE-labelled T. forsythia in the 
presence or absence of P. gingivalis. After 1 hour of infection at an MOI of 100, the 
percentage of macrophages that phagocytosed T. forsythia in the absence of P. 
gingivalis was minimal (ca. 4%). Coinfection with P. gingivalis even at an MOI of 
10 doubled the percentage, and further increase in the MOIs of P. gingivalis 
significantly enhanced the phagocytosis of T. forsythia in an MOI-dependent 
manner (Fig. 18A and B). Mixed infection of P. gingivalis and T. forsythia at an 
MOI of 100 resulted in more phagocytosis of T. forsythia than did monoinfection 




















Figure 18. P. gingivalis promotes phagocytosis of T. forsythia in an MOI-
dependent manner. THP-1 cells were infected with CFSE-labelled T. forsythia 
and unlabelled P. gingivalis at the indicated MOI for 1 hour. (A) Histograms of the 
infected macrophages (solid lines) are shown with the mean percentage of 
macrophages positive for phagocytosed T. forsythia. Uninfected cells are shown as 
the gray-filled histogram. (B, C) The mean fluorescence intensity (MFI) of the 
infected macrophages is shown as the mean ± standard deviation. The 
representative data of two independent experiments are shown. Tf, T. forsythia; Pg, 
P. gingivalis. * P < 0.05 compared to T. forsythia monoinfection; # P < 0.05 




2.2. P. gingivalis gingipains are essential for the enhancement of phagocytosis 
of T. forsythia  
Gingipain mutant strains of P. gingivalis were used in the mixed infections to 
determine the role of gingipains in the enhancement of T. forsythia phagocytosis. 
The increase in the phagocytosis of T. forsythia was solely dependent on gingipains 
of P. gingivalis, because the increase was not observed when THP-1 cells were 
infected with T. forsythia in the presence of the gingipain-null mutant (KDP136) 
(Fig. 19A and B). Kgp- or Rgp-deficient mutants (KDP129 or KDP133, 
respectively) significantly facilitated the phagocytosis of T. forsythia, and the 
increase induced by the two mutant strains was similar. However, the increase in 
the proportion of T. forsythia-phagocytosing cells and the mean fluorescence 
intensity were about two-thirds and one-third of those induced by wild-type P. 
gingivalis, respectively (Fig. 19A and B). It was determined whether phagocytosis 
of T. forsythia is also enhanced by P. gingivalis in PBMC-derived macrophages. T. 
forsythia was more efficiently phagocytosed by PBMC-derived macrophages than 
by THP-1 cells, and P. gingivalis coinfection further increased T. forsythia 
phagocytosis in a gingipain-dependent manner (Fig. 19C and D). Confocal 
microscopy confirmed that CFSE-labelled T. forsythia was more abundantly 
internalized by THP-1 cells when the cells were coinfected with wild-type P. 
gingivalis than with KDP129 or KDP133, and the gingipain-null mutant KDP136 
had no effect on the uptake of T. forsythia by macrophages (Fig. 19E). These 
results indicate that gingipains of P. gingivalis are major factors contributing to the 
augmentation of T. forsythia phagocytosis in mixed infections, and that both Kgp 




Figure 19. Gingipain mutations in P. gingivalis attenuate the enhancement of 
phagocytosis of T. forsythia. THP-1 cells (A, B, and E) and PBMC-derived 
macrophages (C, D) were infected with CFSE-labelled T. forsythia and unlabelled 
P. gingivalis at an MOI of 100 for 1 hour. (A, C) Histograms of the infected 
macrophages (solid lines) are shown with the mean percentage of macrophages 
positive for phagocytosed T. forsythia. The uninfected cells are shown as the gray-
filled histogram. (B, D) The mean fluorescence intensity (MFI) of the infected 
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macrophages is shown as the mean ± standard deviation. The representative data of 
three independent experiments are shown. (E) The macrophages were fixed and 
examined under a confocal laser scanning microscope after staining F-actin (red) 
and nuclei (blue). CFSE-labelled T. forsythia is displayed in green. Tf, T. forsythia; 
Pg, P. gingivalis; WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, 
KDP133 (rgpA- rgpB-); 136, KDP136 (kgp- rgpA- rgpB-). * P < 0.05 compared to T. 





















2.3. T. forsythia augments phagocytosis of P. gingivalis  
To examine whether T. forsythia coinfection influences phagocytosis of P. 
gingivalis, THP-1 cells were infected with CFSE-labelled P. gingivalis in the 
presence or absence of T. forsythia. Although P. gingivalis was phagocytosed well 
in monoinfection, T. forsythia coinfection further enhanced its phagocytosis in an 
MOI-dependent manner (Fig. 20A and B). When phagocytosis of gingipain 
mutants was assessed, the enhancement by T. forsythia was observed only in 
phagocytosis of wild-type P. gingivalis and KDP129, but not KDP133 nor KDP136 
(Fig. 20C and D), indicating that the enhancement of P. gingivalis phagocytosis by 
T. forsythia is dependent on Rgps. It was also found that in contrast to the most 
substantial enhancement of T. forsythia phagocytosis by wild-type P. gingivalis 
(Fig. 19), wild-type P. gingivalis was less phagocytosed than KDP129 or KDP133 














Figure 20. Phagocytosis of P. gingivalis is facilitated by T. forsythia. (A, B) 
THP-1 cells were infected with unlabelled T. forsythia and CFSE-labelled wild-
type P. gingivalis at the indicated MOI for 1 hour. (C, D) THP-1 cells were infected 
with unlabelled T. forsythia and CFSE-labelled wild-type P. gingivalis or its 
gingipain mutants at an MOI of 100 for 1 hour. The percentage of macrophages 
positive for phagocytosed P. gingivalis (A, C) and the mean fluorescence intensity 
(MFI) of the infected macrophages (B, D) are shown as the mean ± standard 
deviation. The relative MFI is calculated as (MFI of the infected macrophages) / 
(the MFI of each P. gingivalis strain). Tf, T. forsythia; Pg, P. gingivalis; WT, P. 
gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 (rgpA- rgpB-); 136, 
KDP136 (kgp- rgpA- rgpB-). * P < 0.05 compared to P. gingivalis monoinfection; # 




2.4. Coaggregation of T. forsythia with P. gingivalis that expresses gingipains 
contributes to the augmentation of phagocytosis of T. forsythia 
To determine whether direct interaction of T. forsythia with P. gingivalis is 
required for the enhancement of T. forsythia phagocytosis, coaggregation between 
the two bacterial species and the effect of its inhibition on phagocytosis of T. 
forsythia were examined. T. forsythia coaggregated well (63% reduction of initial 
OD) with wild-type P. gingivalis (Fig. 21A), and the coaggregation was markedly 
inhibited by two basic amino acids, arginine and lysine (Fig. 21A). They also 
significantly alleviated the enhancement of T. forsythia phagocytosis by wild-type 
P. gingivalis in a dose-dependent manner (Fig. 21B). Histidine, the other basic 
amino acid, also moderately reduced the coaggregation and phagocytosis of T. 
forsythia in a concentration-dependent manner, although the inhibitory effect was 
weaker than those of arginine and lysine (Fig. 21A and B). In contrast, glycine, a 
neutral amino acid, had a minimal suppressive effect on phagocytosis of T. 
forsythia, although its inhibitory effect on coaggregation was comparable to that of 
histidine (Fig.21A and B). However, it is not clear whether the inhibitory effect of 
Arg, Lys, and His depends on their positive charges or whether Arg, Lys, and His 
residues in the outer membrane proteins are involved in the protein-protein 
interaction for the coaggregation.  
Next, the coaggregating ability of gingipain mutants of P. gingivalis with T. 
forsythia was assessed. Coaggregation of P. gingivalis with T. forsythia was 
entirely dependent on gingipains because P. gingivalis KDP136 did not 
coaggregate with T. forsythia (Fig. 22A). The inhibitory effect of basic amino acids 
on coaggregation and on phagocytosis of T. forsythia in mixed infection with P. 
gingivalis KDP136 was negligible and similar to that observed in monoinfection 
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with T. forsythia (Fig. 22A and B). While P. gingivalis KDP129 or KDP133 
coaggregated well with T. forsythia, the coaggregation was inhibited considerably 
by arginine and lysine, and weakly by histidine, but not by glycine (Fig. 22A). 
Likewise, phagocytosis of T. forsythia in mixed infection with either of the two 
mutants was suppressed extensively by arginine and lysine, and mildly by histidine, 
but not by glycine (Fig. 22B). These results indicate that the augmentation of T. 
forsythia phagocytosis in mixed infection with P. gingivalis requires direct 
interaction between the two species of bacteria, and that gingipains are key 




















Figure 21. Inhibition of coaggregation reverses the boosting of T. forsythia 
phagocytosis by P. gingivalis. (A) Coaggregation activity between T. forsythia and 
wild-type P. gingivalis in the presence or absence of the indicated concentration of 
L-Arg, L-Lys, His, or Gly was measured as decrease (%) in OD660 after 90 min. * P 
< 0.05 compared to coaggregation in the absence of the amino acids. (B) 
Phagocytosis of CFSE-labelled T. forsythia by THP-1 cells was analyzed after 1 
hour of infection at an MOI of 100 in the presence or absence of wild-type P. 
gingivalis and the indicated concentration of the amino acids. The percentage of 
macrophages positive for phagocytosed T. forsythia is shown as the mean ± 
standard deviation. The representative data of two independent experiments are 
shown. Tf, T. forsythia ; Pg, P. gingivalis. * P < 0.05 compared to T. forsythia 
monoinfection; # P < 0.05 compared to coinfection with wild-type P. gingivalis in 




Figure 22. Gingipain-dependent coaggregation mediates the augmentation of 
phagocytosis of T. forsythia. (A) Coaggregation activity between T. forsythia and 
wild-type P. gingivalis or its gingipain mutants in the presence or absence of 50 
mM L-Arg, L-Lys, His, or Gly was quantitated as decrease (%) in OD660 after 90 
min. * P < 0.05 compared to coaggregation in the absence of the amino acids. (B) 
Phagocytosis of CFSE-labelled T. forsythia by THP-1 cells was analyzed after 1 
hour of infection at an MOI of 100 in the presence or absence of P. gingivalis and 
50 mM of the indicated amino acids. The percentage of macrophages positive for 
phagocytosed T. forsythia is shown as the mean ± standard deviation. The 
representative data of two independent experiments are shown. Tf, T. forsythia; Pg, 
P. gingivalis; WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 
(rgpA- rgpB-); 136, KDP136 (kgp- rgpA- rgpB-). # P < 0.05 compared between the 
two groups.  
73 
 
2.5. Protease activities of P. gingivalis gingipains are partially responsible for 
the facilitation of phagocytosis of T. forsythia 
To investigate the role of gingipain protease activities in the enhancement of 
phagocytosis of T. forsythia, wild-type P. gingivalis was preincubated with KYT-36 
or KYT-1 to inhibit Kgp or Rgps, respectively, shortly before infection. The 
inhibition of Kgp or Rgps of wild-type P. gingivalis significantly attenuated the 
enhancement of T. forsythia phagocytosis, with more reduction observed in the 
Kgp-inhibited P. gingivalis (Fig. 23A and B). The inhibition of both Kgp and Rgps 
further reduced the increment of T. forsythia phagocytosis. This result indicates that 
the protease activities of both Kgp and Rgps are required to maximally boost 
phagocytosis of T. forsythia in mixed infection with P. gingivalis, although other 
functions of gingipains may also be involved. Next, it was determined whether the 
protease activities of gingipains contribute to the enhanced phagocytosis via 
coaggregation between the two species of bacteria. The inhibition of Kgp or Rgps 
of wild-type P. gingivalis significantly lessened the coaggregation (Fig. 23C) in a 
manner similar to the reduction in phagocytosis of T. forsythia (Fig. 23A and B), 
suggesting that the protease activities of gingipains may contribute to the 










Figure 23. Protease activities of gingipains partially contribute to the 
enhancement of phagocytosis of T. forsythia. (A, B) THP-1 cells were infected at 
an MOI of 100 for 1 hour with CFSE-labelled T. forsythia and unlabelled wild-type 
P. gingivalis that had been preincubated with 10 μM KYT-36 (for Kgp inhibition) 
or KYT-1 (for Rgp inhibition) for 1 hour. Histograms with the mean percentage of 
macrophages positive for phagocytosed T. forsythia (A) and the mean fluorescence 
intensity (MFI) of the infected macrophages (B) are shown. * P < 0.05 compared 
to T. forsythia monoinfection; # P < 0.05 compared to coinfection with wild-type P. 
gingivalis without preincubation with KYT-1 or KYT-36. (C) Coaggregation 
activity between T. forsythia and wild-type P. gingivalis that had been preincubated 
with KYT-36 or KYT-1 was measured as decrease (%) in OD660 after 90 min. The 
representative data of two independent experiments are shown as the mean ± 
standard deviation. # P < 0.05 compared to coaggregation of T. forsythia and P. 
gingivalis without preincubation with KYT-1 or KYT-36. Tf, T. forsythia; Pg WT, P. 
gingivalis ATCC 33277.  
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2.6. Direct effect of soluble gingipains on T. forsythia is minimal 
To investigate whether protease activities have a direct effect on T. forsythia, 
VDS of P. gingivalis was used. Preincubation of T. forsythia with VDS of P. 
gingivalis expressing gingipains led to a slight increase in T. forsythia phagocytosis, 
and this increase was reversed by the gingipain-specific inhibitor KYT-36 (Fig. 
24A and B). In contrast, infection of macrophages with T. forsythia in the presence 
or absence of P. gingivalis VDS after preincubation of the cells with P. gingivalis 
VDS resulted in a minimal decrease in T. forsythia phagocytosis, which was not 
reversed by gingipain inhibitors (Fig. 24C and D). These results indicate that 
changes in macrophages induced by P. gingivalis VDS, possibly by some factors 
other than gingipains, do not contribute to the enhancement of T. forsythia 
phagocytosis. Taken together, these results suggest that gingipains might expose T. 
forsythia epitopes although the effect is minimal and that other mechanisms of 
protease activities of gingipains may be involved in the substantial increase of T. 













Figure 24. Preincubation of T. forsythia with culture supernatants containing 
gingipains minimally enhances phagocytosis of T. forsythia. (A, B) CFSE-
labelled T. forsythia was preincubated with fresh culture media containing 30% 
VDS of P. gingivalis in the presence or absence of KYT-1 or KYT-36. THP-1 cells 
were then infected with the T. forsythia for 1 hour. (C, D) THP-1 cells were 
preincubated for 1 hour with VDS of P. gingivalis (equivalent to an MOI of 100) in 
the presence or absence of KYT-1 or KYT-36. The cells were then infected for 1 
hour with CFSE-labelled T. forsythia in the presence (C) or absence (D) of P. 
gingivalis VDS. The percentage of macrophages positive for phagocytosed T. 
forsythia and the mean fluorescence intensity (MFI) of the infected macrophages 
are shown as the mean ± standard deviation. * P < 0.05 compared to T. forsythia 
without preincubation with P. gingivalis VDS; # P < 0.05 compared between the 
two groups. Tf, T. forsythia; Pg, P. gingivalis; WT, P. gingivalis ATCC 33277; 129, 
KDP129 (kgp-); 133, KDP133 (rgpA- rgpB-); 136, KDP136 (kgp- rgpA- rgpB-).  
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2.7. More T. forsythia remain viable in the infected cells in P. gingivalis 
coinfection 
To examine the effect of P. gingivalis on the persistence of phagocytosed T. 
forsythia, the presence of CFSE-labelled T. forsythia remaining in infected 
macrophages up to 48 hours post-infection was measured using flow cytometry and 
confocal microscopy. In monoinfection with T. forsythia or coinfection with P. 
gingivalis KDP136, the intracellular load of T. forsythia remained minimal from 0 
to 48 hours post-infection. After infection with T. forsythia in the presence of P. 
gingivalis expressing gingipains, which resulted in more phagocytosis of T. 
forsythia, the percentage of macrophages with intracellular T. forsythia and the 
mean fluorescence intensity gradually declined over time (Fig. 25A), indicating 
clearance of the phagocytosed T. forsythia. However, more T. forsythia seemed to 
remain in the infected cells, even after 48 hours, if the cells were coinfected with 
gingipain-expressing P. gingivalis than if they were infected with T. forsythia alone 
or coinfected with the gingipain-null mutant, KDP136 (Fig. 25A and B).  
To determine whether P. gingivalis infection modulates phagosomal 
maturation after T. forsythia phagocytosis, colocalization of CFSE-labelled bacteria 
with lysosomes was examined using LysoTracker Red. In P. gingivalis 
monoinfection, KDP129 and KDP133 induced more acidified phagolysosomes 
than the wild-type (Fig. 26). This is consistent with the phagocytosis results of P. 
gingivalis in monoinfection (Fig. 20C and D), indicating that phagocytosis of P. 
gingivalis induces phagosomal maturation. Most intracellular P. gingivalis 
colocalized with lysosomes. On the contrary, T. forsythia infection alone did not 
induce acidification of phagosomes (Fig. 27). In mixed infection with T. forsythia 
and P. gingivalis, acidification of phagosomes was more intense after coinfection 
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with P. gingivalis KDP129 and KDP133 than coinfection with the wild-type (Fig. 
27), which is similar to those after P. gingivalis monoinfection (Fig. 26). While 
some intracellular T. forsythia colocalized with mature phagosomes after 
coinfection with P. gingivalis, the other intracellular T. forsythia did not. These 
results imply that T. forsythia alone does not induce phagosomal maturation and 
that phagosomes containing T. forsythia can undergo maturation when they also 
contain P. gingivalis. 
RNA-based viability assay using T. forsythia-specific 16S rRNA revealed that 
the number of viable T. forsythia within the infected cells decreases over time, with 
1-2% of initial bacterial load remaining viable after 48 hours (Fig. 28A, on a 
logarithmic scale; 28B, on a linear scale). This result indicates that clearance of T. 
forsythia can be accelerated by P. gingivalis coinfection. Nevertheless, the number 
of viable T. forsythia within macrophages was higher after coinfection with P. 
gingivalis expressing gingipains than after monoinfection with T. forsythia or 




Figure 25. Most T. forsythia is cleared in macrophages, but with more T. 
forsythia remaining after coinfection with P. gingivalis than after 
monoinfection. After THP-1 cells were infected with CFSE-labelled T. forsythia 
and unlabelled P. gingivalis at an MOI of 100 for 1 hour, extracellular bacteria 
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were killed by incubation with 300 μg/ml gentamicin and 200 μg/ml metronidazole 
for 1 hour. The cells were then further incubated for the indicated time. (A) The 
percentage of macrophages positive for remaining T. forsythia and the mean 
fluorescence intensity (MFI) of the infected macrophages are shown as the mean ± 
standard deviation. The representative data of two independent experiments are 
shown. * P < 0.05 compared to T. forsythia monoinfection. (B) After 24 and 48 
hours of infection, the cells were fixed and examined under a confocal laser 
scanning microscope after staining F-actin (red) and nuclei (blue). CFSE-labelled T. 
forsythia is displayed in green. The representative data of two independent 
experiments are shown. Tf, T. forsythia; Pg, P. gingivalis; WT, P. gingivalis ATCC 



















Figure 26. Phagocytosis of P. gingivalis induces phagosomal maturation. After 
THP-1 cells were infected with CFSE-labelled P. gingivalis at an MOI of 100 for 1 
or 3 hours, the cells were stained with LysoTracker Red (red) for 30 minutes. The 
cells were fixed and examined under a confocal laser scanning microscope. CFSE-
labelled P. gingivalis is displayed in green. Pg, P. gingivalis; WT, P. gingivalis 
ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 (rgpA- rgpB-); 136, KDP136 





Figure 27. Some T. forsythia were found in mature phagosomes after 
coinfection with P. gingivalis. After THP-1 cells were infected with CFSE-
labelled T. forsythia and unlabelled P. gingivalis at an MOI of 100 for 1 or 3 hours, 
the cells were stained with LysoTracker Red (red) for 30 minutes. The cells were 
fixed and examined under a confocal laser scanning microscope. CFSE-labelled T. 
forsythia is displayed in green. Tf, T. forsythia; Pg, P. gingivalis; WT, P. gingivalis 
ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 (rgpA- rgpB-); 136, KDP136 







Figure 28. More T. forsythia remains viable within infected macrophages after 
coinfection with P. gingivalis expressing gingipains. After 1 hour of infection 
with T. forsythia in the presence or absence of P. gingivalis at an MOI of 100, 
extracellular bacteria were killed by incubation with 300 μg/ml gentamicin and 200 
μg/ml metronidazole for 1 hour. The cells were then further incubated for the 
indicated time. Relative amount of T. forsythia-specific 16S rRNA in macrophages 
is shown as the mean ± standard deviation on a logarithmic scale (A) and on a 
linear scale (B). The representative data of two independent experiments are shown. 
* P < 0.05 compared to T. forsythia monoinfection. Tf, T. forsythia; Pg, P. 
gingivalis; WT, P. gingivalis ATCC 33277; 129, KDP129 (kgp-); 133, KDP133 




2.8. More T. forsythia-infected cells remain viable in the presence of P. 
gingivalis 
Next, the effect of P. gingivalis coinfection on viability of macrophages was 
examined. Interestingly, the cell viability was increased by coinfection with wild-
type P. gingivalis while it was decreased by T. forsythia monoinfection (Fig. 29). 
Coinfection with KDP129 or KDP133 also slightly increased the cell viability 
while KDP136 did not. Together, these results indicate that P. gingivalis 
coinfection leads to more viable T. forsythia within more macrophages even after 




























Figure 28. Coinfection with P. gingivalis improves the viability of macrophages 
infected with T. forsythia. The cell viability was assessed using the Cell Counting 
Kit-8 (CCK-8) after THP-1 cells were infected with T. forsythia in the presence or 
absence of P. gingivalis at an MOI of 100 for 24 or 48 hours. The representative 
data of two independent experiments are shown as the mean ± standard deviation. 
Tf, T. forsythia; Pg, P. gingivalis; WT, P. gingivalis ATCC 33277; 129, KDP129 
(kgp-); 133, KDP133 (rgpA- rgpB-); 136, KDP136 (kgp- rgpA- rgpB-). * P < 0.05 






1. Role of gingipains in caspase-1 activation 
This study demonstrated that gingipains play complicated roles in P. gingivalis 
infection, resulting in contradictory effects on caspase-1 activation and its 
consequences. On one hand, gingipains positively contribute to the induction of 
caspase-1 activation in infected cells. P. gingivalis with gingipains induced 
caspase-1 activation more efficiently than the gingipain-null mutant, and the 
enhancement of the caspase-1-activating potential of P. gingivalis by gingipains 
was associated with increases in ATP release from the infected macrophages. 
Furthermore, the incubation of the gingipain-null mutant in the gingipain-
containing culture supernatants augmented caspase-1 activation in the mutant-
infected cells, which could be reversed by gingipain inhibitors. On the other hand, 
the protease activity of gingipains had some apparently contradictory effects. The 
inhibition of the protease activity of gingipains during P. gingivalis infection 
potentiated caspase-1 activation, which was also associated with an increase in ATP 
release from the infected cells. In addition, gingipains proteolytically depleted 
proteins that can propagate inflammation after being released as a result of caspase-
1 activation.  
Some previous studies have reported that P. gingivalis activates NLRP3 and 
AIM2 inflammasomes [121,135,136], while other studies have shown that P. 
gingivalis fails to activate caspase-1 [22,122,137]. The results in this study suggest 
that the protease activities of P. gingivalis have a substantial influence on the result 
and its interpretation. It was found that low MOIs, but not high MOIs, of P. 
gingivalis could induce low levels of IL-1β without detectable active caspase-1 in 
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the culture supernatants of infected cells. This induction could be a result of 
alternative IL-1β processing by P. gingivalis proteases because some microbial 
proteases including Candida albicans and Staphylococcus aureus have been 
demonstrated to process pro-IL-1β to active IL-1β [145-147]. However, further 
experiments using leupeptin precluded the possibility of IL-1β processing by P. 
gingivalis proteases because the inhibition of the bacterial proteases enhanced, 
rather than decreased, IL-1β levels. Moreover, the active subunit (p20) of caspase-1 
was detected by preventing its proteolytic degradation, revealing that P. gingivalis 
infection induces caspase-1 activation. 
This study showed that caspase-1 and LDH in the culture supernatants, which 
are commonly used to determine caspase-1 activation, are susceptible to 
proteolysis by gingipains. This proteolysis may partly explain discrepancies among 
the studies reporting inconsistent results regarding caspase-1 activation by P. 
gingivalis infection [22,121,122,135-137] because the expression and activity of 
gingipains can be different depending on strains and experimental conditions used; 
changes in the growth phase, availability of hemin, and oxidative stress levels 
could feasibly alter the results by affecting gingipains activity [148,149]. These 
findings also indicate that using only protein-based methods (e.g., western blot, 
ELISA, and LDH cytotoxicity assay) can be misleading in the analysis of caspase-
1 activation by pathogens with potent proteolytic activity, supporting the need for 
the development of new analytical tools that can cumulatively assess caspase-1 
activation without being affected by proteolysis. 
Several pathogens use strategies to manipulate inflammasome activation by 
producing inhibitors that block inflammasome activation or by regulating the 
production or recognition of bacterial ligands that trigger inflammasomes [150]. It 
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has been reported that P. gingivalis differentially regulates the gene expression of 
inflammasome components in different cell types. While the expression of NLRP3 
and AIM2 is increased by P. gingivalis infection in macrophages [121], P. 
gingivalis in a multi-species subgingival biofilm down-regulates the expression of 
NLRP3 in gingival fibroblasts although the expression of caspase-1 is not directly 
affected by the presence of P. gingivalis [151,152]. The biofilm challenge results in 
differential effects on the expression of caspase-1, ASC, and AIM2 depending on 
the bacterial burden [151]: increase at low bacterial load and decrease at high load. 
In the present study, the protein level of IL-1β showed a similar trend although the 
gene expression of IL-1β increased with the increasing MOIs, which may facilitate 
the pathogen survival by disrupting the host immune responses. The gene 
expression of IL-1β is also differently regulated depending on the cell types in 
response to P. gingivalis. While decreasing in gingival fibroblasts, it increases in 
macrophages and monocytes [121,152,153]. Notably, in monocytes, the up-
regulation of IL-1β gene expression is partially dependent on gingipains, whereas 
that of IL-18 is not affected by gingipains [153]. 
P. gingivalis utilizes gingipains to modulate caspase-1 activation and to 
interfere with host defense mechanisms. An interesting observation from this study 
is that gingipains act as modulating factors of ATP release from P. gingivalis-
infected cells. A recent study reported that ATP release, along with lysosomal 
disruption and cytosolic DNA, mediates caspase-1 activation in P. gingivalis-
infected macrophages [121], which is consistent with the result in this study. ATP 
release occurs through both a lytic and non-lytic pathway, and mechanical stimuli 
or agonists of some receptors are known to induce ATP release [154]. Although 
how ATP release is triggered by P. gingivalis infection remains unknown, the 
89 
 
results of this study indicate that gingipains affect the ability of P. gingivalis to 
activate ATP release from the infected cells.  
Gingipains have contradictory effects on caspase-1 activation through 
multilayered mechanisms, including adhesins and protease activity. Overall, 
gingipains, in particular Rgps, facilitate caspase-1 activation of P. gingivalis-
infected cells because the gingipain-null mutant induced a lower degree of caspase-
1 activation than that induced by P. gingivalis with gingipains. This result is the 
consequence of the combined effects of multiple roles of gingipains. First, this 
result could be due to hemagglutinin/adhesin domains of Kgp and RgpA (Fig. 30A) 
because a previous study demonstrated that the adhesin subunits of gingipains 
induce IL-1β secretion from macrophages [155]. In addition, increases in the 
caspase-1-activating potential of the gingipain-null mutant after incubation with 
gingipain-containing supernatants suggests that bacterial proteins processed by 
gingipains contribute to the caspase-1 activation in P. gingivalis-infected cells (Fig. 
30B and 30B’). It is needed to elucidate which proteins contribute to caspase-1 
activation among the bacterial proteins that are processed by gingipains. 
Notably, the protease action of gingipains during the infection process seems 
to have opposite effects. The inhibition of Kgp or Rgps augmented caspase-1 
activation by wild-type P. gingivalis, but the inhibition of both Kgp and Rgp did 
not further enhance caspase-1 activation compared to the inhibition of Kgp or Rgps. 
This result indicates that the combined proteolytic activity of Kgp and Rgps has 
inhibitory effects on caspase-1 activation. However, it is not clear whether Kgp and 
Rgps cleave the same proteins of host cells. Further research using overexpression 
of a gingipain in the mutant strain that is deficient in the other gingipain might give 
an answer to the question. The inhibitory effect of gingipain activity may be 
90 
 
attributed to the proteolytic cleavage of host cell proteins (Fig. 30C). A number of 
studies have reported that P. gingivalis gingipains dysregulate the host immune 
response by proteolytically inactivating or activating host cell surface receptors and 
proteins such as CD14, IL-6R, and protease-activated receptors [156-161]. Because 
the inhibition of gingipain protease activity increased ATP release from the infected 
cells, some host proteins that were rescued from cleavage by Kgp and Rgps may be 
associated with ATP release. Another possibility is that the protease action of Kgp 
and Rgps may expose some cryptic inhibitory receptors and that the inhibition of 
gingipains may prevent the exposure of such inhibitory receptors. Further research 
is needed to determine which host proteins are affected by Kgp or Rgps. 
The proteolysis of host-derived proteins by gingipains is an important 
mechanism used by P. gingivalis to neutralize host defense responses and to evade 
immune systems. The degradation of IL-1β observed in this study (Fig. 30D) is 
consistent with the results of previous studies demonstrating the disruption of 
cytokine networks by P. gingivalis [44,162]. The transient appearance of a smaller 
fragment of IL-1β in this study may result from the partial proteolysis by Rgps at 
Arg120 or Arg127, which can be inferred from the size of the fragment. Whether this 
fragment retains biological activity remains to be determined. Furthermore, this 
study assessed proteolysis of other proteinaceous proinflammatory mediators. 
Recent studies have demonstrated that HMGB1, inflammasome particles, and ASC 
specks amplify inflammatory responses after being released into the extracellular 
milieu following inflammasome activation [142-144]. Notably, all of these proteins 
were cleared by P. gingivalis through proteolysis, mainly by gingipains (Fig. 7D). 
The rate of degradation and susceptibility to each gingipain may depend on the 




Figure 30. Plausible roles of gingipains in caspase-1 activation and its sequelae 
following P. gingivalis infection. The presence of gingipains in P. gingivalis 
promotes ATP release, thereby contributing to the activation of the NLRP3 
inflammasome and caspase-1. Hemagglutinin/adhesin domains of Kgp and Rgps 
(A) and other bacterial surface proteins (B’) processed by gingipains (B) would 
contribute to the enhancement of caspase-1 activation. However, the collaborative 
protease activity of Kgp and Rgps during the infection process, possibly through 
the cleavage of host proteins, decreases the level of ATP released from the infected 
cells, resulting in the attenuation of caspase-1 activation (C). Moreover, IL-1β, 
HMGB1, and inflammasome components, which are released from caspase-1-
activated cells and amplify inflammation, are proteolytically depleted by gingipains 
(D). This depletion may prevent the recruitment of immune cells and the clearance 
of P. gingivalis, allowing for persistent infection and systemic dissemination. IM, 
inner membrane of P. gingivalis; OM, outer membrane of P. gingivalis; PM, 
plasma membrane of a host cell.  
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2. Role of gingipains in augmentation of T. forsythia 
phagocytosis  
The present study demonstrated that coinfection with P. gingivalis boosted 
phagocytosis of T. forsythia by macrophages, and that both Rgps and Kgp of P. 
gingivalis were essential for the maximal boosting. The increase in phagocytosis of 
T. forsythia was dependent on the coaggregation between the two species of 
bacteria, which was also dependent on P. gingivalis gingipains. The contribution of 
gingipains seemed to involve both protease and non-protease activities. Coinfection 
with P. gingivalis did not prevent the clearance of the phagocytosed T. forsythia, 
but more T. forsythia remained in cells that were coinfected with gingipain-
expressing P. gingivalis than in cells that were infected with T. forsythia alone. 
Pathological tissue destruction in periodontal diseases results from host 
responses to polymicrobial biofilms accumulated in the subgingival area, and 
synergistic virulence of periodontal pathogens in animal models has been reported 
[79,164,165]. Therefore, it is important to understand the host responses not only to 
each bacterial species but also to mixed infections. The facilitated phagocytosis of 
T. forsythia and P. gingivalis by each other may contribute to their synergistic 
pathogenicity in vivo such as abscess formation and alveolar bone loss in murine 
models [79,80]. 
Gingipains are not only essential for the pathogenicity of P. gingivalis 
monoinfection but are also indispensable for the synergistic virulence of P. 
gingivalis and T. forsythia, including abscess formation [79], IL-6 production in 
macrophages [85], and stimulation of each other’s growth [81,82], as well as 
inactivation of complement pathways [72]. In this study, the enhancement of T. 
forsythia phagocytosis by P. gingivalis was also completely dependent on the 
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presence of Kgp and Rpgs, because deficiency in either gingipain in P. gingivalis 
significantly decreased the enhancement, while the gingipain-null mutant did not 
have any effect on the phagocytosis. Protease actions of gingipains during the 
infection process were partly responsible for the ability of P. gingivalis to promote 
T. forsythia phagocytosis. However, direct effect of gingipain protease activities on 
T. forsythia seems miniscule, because preincubation of T. forsythia in the VDS of P. 
gingivalis only minimally increased phagocytosis of T. forsythia.  
Gingipains seem to contribute to the enhancement of T. forsythia phagocytosis 
by mediating the interaction between the two species of bacteria, because inhibition 
of bacterial coaggregation significantly reduced the enhancement, and the lack of 
gingipains abrogated the coaggregation. The largest increase in T. forsythia 
phagocytosis by wild-type P. gingivalis despite less phagocytosis of itself than 
KDP129 or KDP133 suggests that the phagocytosis of T. forsythia was increased 
via complex interactions between the two bacterial species and macrophages. 
Phagocytosis of bacteria by macrophages involves multiple receptors and signaling 
pathways [166,167], and the bacterial coaggregate may harbor more ligands that 
can lead to receptor clustering and activation of the signaling pathways than does 
either individual bacterial species, possibly resulting in facilitation of phagocytosis. 
However, the exact mechanisms by which gingipains mediate the coaggregation of 
P. gingivalis and T. forsythia and by which the coaggregation promotes 
phagocytosis of T. forsythia remain to be elucidated.  
Inhibition of coaggregation by amino acids, in particular arginine and lysine, 
suggests that protein-protein interactions may mediate the coaggregation. Previous 
studies have demonstrated the role of the adhesin domains of gingipains and the 
contribution of gingipains via processing of other adhesins to coaggregation of P. 
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gingivalis with other bacterial species, such as T. denticola, Prevotella intermedia, 
and Actinomyces viscosus [168-170]. These studies are consistent with the 
observations that gingipains are required for coaggregation and that inhibition of 
protease activities only partially reduces the coaggregation. Adhesins of P. 
gingivalis that are processed by gingipains and contribute to coaggregation with T. 
forsythia have to be elucidated. 
It has been reported that the S-layer of T. forsythia, but not BspA, is involved 
in coaggregation with P. gingivalis [67,171]. In addition, T. forsythia S-layer delays 
immune responses in macrophages [69]. It also has been reported that 
glycosylation of T. forsythia S-layer protects the bacteria from binding to DCs and 
regulates cytokine expression in DCs and macrophages [70]. Therefore, T. forsythia 
S-layer or its glycosylation might contribute to the low phagocytosis rate of T. 
forsythia by hindering the bacteria from binding to macrophages, and protein 
expression or glycosylation of T. forsythia S-layer might be affected by P. 
gingivalis. However, further research to explore this possibility is needed. 
Porphyromonas gingivalis infection impairs epithelial integrity and facilitates 
the invasion of oral bacteria into gingival tissues [172], and recruits macrophages 
to gingival tissues [92]. Therefore, the chance for T. forsythia to be phagocytosed 
by macrophages will further increase. Enhanced phagocytosis of T. forsythia by 
macrophages in coinfection with P. gingivalis can contribute to efficient clearance 
of the invading bacteria. However, more T. forsythia remained viable in 
macrophages coinfected with P. gingivalis after 24 and 48 hours than in 
monoinfected cells although P. gingivalis did not prevent the clearance of T. 
forsythia. In addition, macrophages coinfected with T. forsythia and P. gingivalis 
remained more viable than the cells infected only with T. forsythia. Considering 
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that macrophages can migrate from inflamed tissues to lymph nodes [173,174], the 
detection of periodontal pathogens, including P. gingivalis and T. forsythia, in 
lymph nodes draining the oral cavity [175], and possibly in distant sites such as 
atherosclerotic lesions and placenta [176,177], may be attributable to the 
intracellular bacteria that remains in infected macrophages. Given that oral 
infection with P. gingivalis increases macrophage infiltration in draining lymph 
nodes [92], coinfection with P. gingivalis may facilitate systemic dissemination of 
T. forsythia. Further research is required to determine whether the enhanced 
phagocytosis of T. forsythia contributes to host defenses by efficient clearance, or 
contributes to systemic dissemination of the invading bacteria.  
To summarize, gingipain-dependent enhancement by P. gingivalis of T. 
forsythia phagocytosis was observed in macrophages, and this enhancement was 
mediated by coaggregation of the two bacterial species. More T. forsythia remained 
viable in macrophages after mixed infection with gingipain-expressing P. gingivalis 
than after monoinfection with T. forsythia. These results imply that the presence of 
P. gingivalis and its gingipains influences the clearance of T. forsythia and may 











3. Pathological and clinical implication  
Because gingipains are essential to the pathogenicity of P. gingivalis, they 
represent promising therapeutic targets for the prevention and treatment of 
periodontitis and other P. gingivalis-associated diseases. The present study 
demonstrates that several functions of Rgps and Kgp can differentially and 
contradictorily contribute to the pathogenicity.  
A previous study has shown the increased expression of caspase-1 and other 
inflammasome components (NLRP3 and AIM2) in the gingival tissue of 
periodontal patients [121]. Gingipain-dependent caspase-1 activation in P. 
gingivalis-infected macrophages observed in this study may contribute to the 
exacerbation of inflammation through release of proinflammatory mediators.  
Interestingly, the protease activities of gingipains exhibit inhibitory effects on 
caspase-1 activation while they positively contribute to the enhancement of T. 
forsythia phagocytosis. Attenuation of inflammasome activation and deactivation 
of proteinaceous proinflammatory mediators by the protease activity of gingipains 
may help P. gingivalis and coinfecting T. forsythia avoid detection by the host 
defense system. This avoidance may offer a survival advantage to P. gingivalis and 
T. forsythia, and possibly other co-infecting microorganisms in polymicrobial 
infections. In addition, P. gingivalis may contribute to dissemination of coinfecting 
T. forsythia by increasing the number of uncleared bacteria in infected 
macrophages, and by promoting migration of the macrophages into systemic 
circulation.  
Due to complicated functions of gingipains, the preventive/therapeutic 
outcomes of gingipain inhibitors may vary depending on the therapeutic 
approaches. For example, transient inhibition of protease activities of gingipains 
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may not only enhance caspase-1 activation and the release of IL-1β and DAMPs, 
but it may also preserve proinflammatory mediators in infection sites. In contrast, 
the prolonged use of gingipain inhibitors or inhibitors targeting the expression of 
gingipains may lead to a decrease in caspase-1 activation. In mixed infection, 
inhibition of gingipains will decrease phagocytosis of T. forsythia within gingival 
tissue. This may result in ineffective clearance of the bacteria although it might 
reduce the possibility of the bacterial dissemination.  
For the clinical application of the findings in this study, the following 
questions need be answered: How do gingipains modulate ATP release from P. 
gingivalis-infected macrophages?; whether are caspase-1-dependent effector 
mechanisms protective or deleterious in P. gingivalis-induced chronic 
inflammation?; whether is the enhancement of T. forsythia phagocytosis by P. 
gingivalis detrimental due to eliciting excessive inflammatory response, or 
protective through eliminating the infecting bacteria?; Does P. gingivalis increase 
the possibility of distant dissemination of T. forsythia? The answers to the 
questions will provide insight into which functions of gingipains should be targeted 












Considering that gingipains are one of major promising therapeutic targets in 
preventive and therapeutic strategies, it is of great importance to fully characterize 
the roles of gingipains in the pathogenicity of P. gingivalis. The present study 
demonstrated that gingipains play contradictory roles in caspase-1 activation in P. 
gingivalis monoinfection, and that gingipains are essential in augmentation of T. 
forsythia phagocytosis in mixed infection. These results illuminate the complicated 
roles of gingipains in the manipulation of host defense systems. This study 
provides clues to advance our understanding of the role of gingipains in the 
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목   
Porphyromonas gingivalis는 주염 병인에  구강내 균  불균  도
하고, 이에 한 주 면역  란시키는 주요 병원균  작용한다. 
Arg-gingipains (RgpA, RgpB)과 Lys-gingipain (Kgp)  종종 주질   
연 질 에 한 / 료  개 에 있어 이 는 이 균  주요 독  
인자이다. 이 연구  목  1) 식 포에  P. gingivalis에 한 caspase-1 
에 있어 gingipain  역할  규명하고, 2) Tannerella forsythia  
합 감염에  P. gingivalis가 식 포에 한 T. forsythia 포식작용에 미 는 
향  알아보고, 이에 있어 gingipain  역할  규명하는 것이다.  
 
법 
P. gingivalis 감염에 한 식 포에  caspase-1 에 있어 
gingipain  역할  살펴보  해, phorbol-12-myristate-13-acetate 
 
 
(PMA)  분 시킨 THP-1 식 포 또는 말 액 단핵 포에  래  
식 포를 P. gingivalis 또는 이  gingipain 결핍 돌연변이주  6시간 동안 감
염시켰다. 면역 롯 과, ELISA, lactate dehydrogenase (LDH) 포독 검사
를 이용하여 포 양액 내  caspase-1, interleukin (IL)-1β, LDH를 분
하 다. Gingipain  단 질 분해 효소  역할  살펴보  해, P. 
gingivalis를 leupeptin (시스 인 단 질 가 분해 효소 억 ), 또는 
gingipain-특이 억  (KYT-1, KYT-36)  처리한 후, 식 포에 감염시
켰다. Caspase-1  후 분 / 리 는 단 질  P. gingivalis가 분해하는지 
살펴보  해, 열 사멸 P. gingivalis  자극한 식 포  양액에 P. 
gingivalis를 양한 후 분 하 다. P. gingivalis, gingipain 결핍 돌연변이주, 
또는 gingipain 억  처리한 P. gingivalis를 식 포에 감염시킨 후 
포 내 caspase-1 과 리 는 ATP를 분 하 다. Gingipain에 한 균 
면 단 질 /가공  역할  살펴보  해, gingipain 결핍 돌연변이주를 
gingipain이 포함  균 양액에  양한 후 식 포에 감염시켜 
caspase-1 를 분 하 다.  
P. gingivalis 합 감염이 식 포에 한 T. forsythia 포식작용에 미 는 
향  살펴보  해, PMA  분 시킨 THP-1 식 포 또는 말 액 단핵
포에  래  식 포에 carboxyfluorescein diacetate succinimidyl 
ester (CFSE)  지한 T. forsythia를 P. gingivalis, 또는 gingipain 결핍 돌
연변이주  함께 1시간 감염시킨 후 T. forsythia 포식 도를 포 분
 공  미경  이용하여 인하 다.  균 종간  집  분 하 고, 
균 집  억 하는 아미노산이 T. forsythia 포식작용에 미 는 향  살펴
보았다. Gingipain  단 질 분해 효소  역할  살펴보  해 KYT-1, 
KYT-36  처리한 P. gingivalis를 이용하 다. 균 감염  항생  처리 
 
 
후 포 내 T. forsythia  지속/생존  포 분 , 공  미경, 또는 
16S 리보좀 RNA-  생존 분 법  이용하여 인하 다.  
 
결과  
낮  MOI  P. gingivalis 감염 후 포 양액에 IL-1β  LDH가  양
 존재하나, caspase-1  검출 지 않았 며, 높  MOI에 는 IL-1β  
LDH도 검출 지 않았다. Caspase-1이  포에  리 는 단 질들
이 gingipain에 해 분해 는 것  인하 다. 그러나, gingipain  하는 
P. gingivalis 균주  식 포를 감염시켰  , gingipain이 없는 균주에 
해 포 내 caspase-1 이 높았 며, 이는 감염  포 부  ATP가 
리 는 것과 이 있었다. Gingipain  하지 않는 균주를 gingipain
이 포함  양액에 양한 후 식 포를 감염시켰  , caspase-1 
가 증가하 다. 면, Kgp 또는 Rgp  단 질 분해 효소  억 하  , 
포 내 caspase-1 이 증가하여, Kgp  Rgp 단 질 분해 이 복합
 작용하여 억 효과를 나타냄  인하 다.  
식 포에  P. gingivalis 합 감염이 T. forsythia 포식작용  하게 
증가시켰 며, Kgp 또는 Rgp 돌연변이주  경우, 그 증가 도가 감소하 다. 
 균 종간  집에 gingipain이 여함  인하 며, 집  억 하  
 T. forsythia 포식작용  증가가 약 었다. Gingipain  단 질 분해 효소 
 억 하  , T. forsythia 포식작용이 감소하 다. 감염 24, 48시간 
후 포 내에  부분  T. forsythia가 거 었 나, T. forsythia 단독 감염
에 해 gingipain  하는 P. gingivalis  합 감염 후 포 내에 살아






Gingipain이 주요한 료  개  임  고 할 , P. gingivalis  병독
 에  gingipain  역할  이해하는 것이 요하다. 본 연구 결과, P. 
gingivalis 단독 감염에 한 caspase-1 에 있어 gingipain이 복잡하고 
상 는 역할  하며, T. forsythia  합 감염에 는 T. forsythia 포식작
용  증가시키는 데 핵심  역할  한다. 
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